NCT Number,Study Title,Study URL,Study Results,Conditions,Interventions,Sex,Age,Phases,Locations
NCT05594316,New Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05594316,NO,Alopecia Areata,DRUG: Trichloroacetic acid,ALL,"CHILD, ADULT",NA,"Al-Azhar university, faculty of medicine, Cairo, Egypt|Al-Azhar university, Cairo, Egypt"
NCT05744505,1565nm Non-ablative Fractional Laser Treat Alopecia Areata,https://clinicaltrials.gov/study/NCT05744505,NO,Alopecia Areata,PROCEDURE: 1565nm Non-ablative Fractional Laser|PROCEDURE: placebo,ALL,ADULT,NA,"Xianjie Wu, Hangzhou, Zhejiang, 310009, China"
NCT04833179,Fecal Transplant for Alopecia Areata,https://clinicaltrials.gov/study/NCT04833179,NO,Alopecia Areata,BIOLOGICAL: fecal transplant|OTHER: placebo,ALL,"ADULT, OLDER_ADULT",NA,
NCT06088147,Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT06088147,NO,Alopecia Areata,DRUG: Methotrexate|DRUG: Triamcinolone Acetonide,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Al-Azhar University, Assiut, Egypt"
NCT06087796,Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.,https://clinicaltrials.gov/study/NCT06087796,NO,Alopecia Areata,DRUG: Betamethasone Valerate 0.1% Cream|DRUG: Pentoxifylline|DRUG: Metformin,ALL,"CHILD, ADULT",PHASE1,"Assiut university, Assiut, 71515, Egypt"
NCT05865041,Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants,https://clinicaltrials.gov/study/NCT05865041,NO,Alopecia Areata,DRUG: Farudodstat|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"1 Site, Birmingham, Alabama, 35205, United States|1 Site, Fountain Valley, California, 92708, United States|1 Site, Santa Ana, California, 92701, United States|1 Site, New Haven, Connecticut, 06519, United States|1 Site, Washington, District of Columbia, 20037, United States|1 Site, Coral Gables, Florida, 33134, United States|1 Site, Indianapolis, Indiana, 46250, United States|1 Site, Louisville, Kentucky, 40241, United States|1 Site, Brighton, Massachusetts, 02135, United States|1 Site, Minneapolis, Minnesota, 55455, United States|1 Site, New Brighton, Minnesota, 55112, United States|1 Site, Saint Joseph, Missouri, 64506, United States|1 Site, Omaha, Nebraska, 68114, United States|1 Site, Cleveland, Ohio, 44195, United States|1 Site, Columbus, Ohio, 43215, United States|1 Site, Nashville, Tennessee, 37215, United States|1 Site, Pflugerville, Texas, 78660, United States|2 Sites, San Antonio, Texas, 78218, United States|1 Site, Webster, Texas, 77598, United States"
NCT05600673,Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05600673,NO,Alopecia Areata,DRUG: Bimatoprost 0.03% solution|DEVICE: CO2 fractional laser,ALL,"CHILD, ADULT",PHASE1|PHASE2,"AL-Azhar University Hospital, Cairo, 11865, Egypt"
NCT04680234,Superficial Cryotherapy Versus Microneedling in Alopecia Areata,https://clinicaltrials.gov/study/NCT04680234,NO,Alopecia Areata,PROCEDURE: DMEP kit|DEVICE: Dermapen,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Sohag Faculty of Medicine, Sohag, 52324, Egypt"
NCT05496426,A Study of KL130008 in Adults With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05496426,NO,Alopecia Areata,DRUG: KL130008/Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangzhou, 510080, China"
NCT05588310,Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors,https://clinicaltrials.gov/study/NCT05588310,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Toulouse University hospital, Toulouse, 31300, France"
NCT05727306,Healthcare Disparities in Alopecia Areata,https://clinicaltrials.gov/study/NCT05727306,NO,Alopecia Areata,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,"Momentum Data Limited, London, United Kingdom"
NCT03732807,PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03732807,YES,Alopecia Areata,DRUG: PF-06651600 Induction Dose|DRUG: PF-06651600 Maintenance Dose #1|DRUG: PF-06651600 Maintenance Dose #2|DRUG: PF-06651600 Maintenance Dose #3|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"The University of Alabama at Birmingham Hospital Outreach Lab, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States|Mosaic Dermatology, Beverly Hills, California, 90211, United States|University of California, Irvine, Department of Dermatology, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Dermatology Specialists, Inc., Murrieta, California, 92562, United States|University of California, San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Aurora, Colorado, 80045, United States|University of Colorado Hospital Outpatient Pavillion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Church Street Research Unit, New Haven, Connecticut, 06519, United States|Medstar Georgetown University Hospital Center-Department of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Washington Hospital Center-Claude Nogay Research Pharmacy, Washington, District of Columbia, 20010, United States|Medstar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Medstar Georgetown University Hospital Center-Department of Pediatrics, Washington, District of Columbia, 20016, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Advanced Clinical Research, Meridian, Idaho, 83642, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Medicine Diagnostic Testing Center, Chicago, Illinois, 60611, United States|Northwestern Medicine, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Investigational Research Pharmacy, Chicago, Illinois, 60611, United States|Northwestern University, Chicago, Illinois, 60611, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of Iowa Hospitals and Clinics; Department of Pharmacy-IDS;, Iowa City, Iowa, 52242, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Medstar Georgetown University Hospital - Department of Dermatology, Chevy Chase, Maryland, 20815, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Investigational Drug Services Attn: Darlette Luke, Minneapolis, Minnesota, 55455, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|The Dermatology Group, P.C., Verona, New Jersey, 07044, United States|NYU School of Medicine, The Ronald O. Perelman Department of Dermatology, New York, New York, 10016, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UNC CTRC, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, Investigational Drug Service, Chapel Hill, North Carolina, 27514, United States|UNC Dermatology Clinical Trials Unit, Chapel Hill, North Carolina, 27516, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Vital Prospects Clinical Research Institute, P.C, Tulsa, Oklahoma, 74136, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|CINME Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Psoriahue Medicina Interdisciplinaria, Caba, C1425DKG, Argentina|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Royal Park Campus, Parkville, Victoria, 3052, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Eastern Canada Cutaneous Research Associates Ltd., Halifax, Nova Scotia, B3H 1Z2, Canada|Guenther Research Inc, London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4C 9M7, Canada|Medicor Research Inc, Sudbury, Ontario, P3A1W8, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centro Internacional de Estudios Clinicos, CIEC, Santiago, Recoleta, 8420383, Chile|Centro Medico Skin Med, Santiago, Región Metropolitana, 7580206, Chile|Clinica Dermacross S.A., Santiago, Región Metropolitana, 7640881, Chile|Medical Skin Center, Vina del Mar, Valparaiso, 2530900, Chile|Peking University First Hospital, Beijing, Beijing, 100034, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China|The University of Hong Kong - Shenzhen Hospital, Shenzhen, Guangdong, 518053, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, China|Huashan Hospital, Fudan University/Dermatology Department, Shanghai, Shanghai, 200040, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|The Second Affiliated Hospital of College of Medicine, Zhejiang University/Dermatology Dept, Hangzhou, Zhejiang, 310009, China|Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China|Fundacion Centro de Investigacion Clinica CIC, Medellin, Antioquia, 050001, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellin, Antioquia, 050010, Colombia|Centro de Investigación en Reumatología y Especialidades Médicas SAS - CIREEM SAS, Bogota, D.c., 110221, Colombia|DERMAMEDICA s.r.o., Nachod, 54701, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Clintrial s.r.o., Praha 10, 100 00, Czechia|Sanatorium profesora Arenbergera, Praha 1, 11000, Czechia|Nemocnice Na Bulovce, Praha 8- Liben, 180 81, Czechia|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Emovis GmbH, Berlin, 10629, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|University Hospital Frankfurt, Frankfurt am Main, 60590, Germany|University Hospital Schleswig-Holstein, Luebeck, 23538, Germany|University Hospital Muenster, Muenster, 48149, Germany|Semmelweis Egyetem, Budapest, 1085, Hungary|Debreceni Egyetem, Debrecen, 4032, Hungary|Bugat Pal Korhaz, Borgyogyaszat, Gyongyos, 3200, Hungary|Szegedi Tudományegyetem Altalanos Orvostudomanyi Kar, Szeged, 6720, Hungary|Nagoya City University Hospital - Dermatology, Nagoya, Aichi, 467-8602, Japan|Tohoku University hospital, Sendai, Miyagi, 980-8574, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, 136-0075, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Sociedad de Metabolismo y Corazon S.C., Veracruz, C.P. 91900, Mexico|Hospital D'Maria, Veracruz, CP. 91910, Mexico|Centermed Krakow Sp.z o.o., Krakow, 31-530, Poland|Medicover Sp.z.o.o, Lodz, 90-368, Poland|Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Sanova Audiological Care Polska Sp.z.o.o, Lodz, 91-867, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|RCMed Oddzial Warszawa, Warszawa, 02-657, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spółka Partnerska, Wroclaw, 50-566, Poland|State Budgetary Healthcare Institution Chelyabinsk Regional Clinical Dermatovenerologic Dispensary, Chelyabinsk, 454092, Russian Federation|University Clinic of Kirov SMU, Kirov, 610035, Russian Federation|Clinical Medical Center of A.I. Yevdokimov MSMSU, Moscow, 111398, Russian Federation|Federal State Autonomous Institution National Medical Research Centre of Childrens Health, Moscow, 119991, Russian Federation|State Budgetary Institution of the Rostov Region ""Dermatovenerologic Dispensary"", Rostov-on-Don, 344002, Russian Federation|Limited Liability Company ""Pierre Volkenshtein Skin Diseases Clinic"", Saint Petersburg,, 191123, Russian Federation|Limited Liability Company ""Centre Vitiligo"" (""Centre Vitiligo"" LLC), Saint Petersburg, 191123, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""Dermatovenerologic Dispensary No. 10 -, Saint Petersburg, 194021, Russian Federation|State Autonomous Healthcare Institution of the Yaroslavl Region Clinical Emergency Hospital, Yaroslavl, 150003, Russian Federation|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Reina Sofía, Servicio Dermatologia, Cordoba, 14004, Spain|Servicio Otorrinolaringologia, Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Servicio Radiologia, Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Servicio de Dermatologia, Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Servicio de Otorrinolaringologia, Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Servicio de Radiologia, Hospital Universitario y Politecnico Le Fe, Valencia, 46026, Spain|CHANG GUNG MEMORIAL HOSPITAL Kaohsiung Branch, Kaohsiung City, 83301, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, 23561, Taiwan|Chung Shan Medical University Hospital, Taichung, 40201, Taiwan|Chung-Shan Medical University Hospital, Taichung, 40201, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Chang Gung Memorial Hospital-Linkou Branch, Taoyuan City, 333, Taiwan|Brighton and Sussex University Hospitals NHS Trust, Brighton, EAST Sussex, BN2 5BE, United Kingdom|Southampton University Hospital NHS Foundation Trust, Royal South Hants Hospital, Southampton, Hampshire, SO14 0YG, United Kingdom|Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 5BE, United Kingdom|NHS Tayside Ninewells Hospital, Dundee, DD1 9SY, United Kingdom|NHS Greater Glasgow and Clyde Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, G51 4TF, United Kingdom|Southampton University Hospital NHS Foundation Trust, University Hospital Southampton, Hampshire, SO16 6YD, United Kingdom|Guy's and St.Thomas' Hospitals NHS Foundation Trust, St.Thomas' Hospital,, London,, SE1 7EH, United Kingdom|Guy's and St.Thomas' Hospitals NHS Foundation Trust, Guy's Hospital,, London,, SE1 9RT, United Kingdom|Harley Grove Medical Centre, London, E3 2AT, United Kingdom"
NCT05866562,Dupilumab in the Treatment of Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05866562,NO,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,CHILD,PHASE2,"University of California, Irvine, Irvine, California, 92697, United States|Yale University, New Haven, Connecticut, 06511, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT06149936,Excimer Light(308) Therapy for Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT06149936,NO,Alopecia Areata,DEVICE: excimer light,ALL,ADULT,,
NCT06402630,"A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)",https://clinicaltrials.gov/study/NCT06402630,NO,Alopecia Areata,DRUG: STS01|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Queen Margaret Hospital, Glasgow, Dunfirmline, KY12 0SU, United Kingdom|St Lukes Hospital, Bradford, Little Horton Lane, BD5 0NA, United Kingdom|Royal Alexandra Children's Hospital, Brighton, BN2 5BE, United Kingdom|University Hospital Coventry & Warwickshire, Coventry, CV2 2DX, United Kingdom|Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|Gloucestershire Royal Hospital, Gloucester, GL1 3NN, United Kingdom|Queen Anne Street Medical Centre Limited, London, W1G 8HU, United Kingdom|Norfolk and Norwich University Hospital, Norwich, NR4 7UY, United Kingdom|Salford Royal Hospital, Salford, M6 8HD, United Kingdom"
NCT05745389,CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry,https://clinicaltrials.gov/study/NCT05745389,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"CorEvitas, LLC, Waltham, Massachusetts, 02451, United States"
NCT01385839,Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata,https://clinicaltrials.gov/study/NCT01385839,NO,Alopecia Areata|Alopecia|Balding,PROCEDURE: Hair transplantation|PROCEDURE: Hypodermic needle irritation,ALL,"ADULT, OLDER_ADULT",NA,"Icahn School of Medicine at Mount Sinai, Department of Dermatology Clinical Trials Center, New York, New York, 10029, United States"
NCT06018428,"Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata",https://clinicaltrials.gov/study/NCT06018428,NO,Alopecia Areata,DRUG: ADX-914|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Scottsdale, Arizona, Scottsdale, Arizona, 85255, United States|Fayetteville, Arkansas, Fayetteville, Arkansas, 72703, United States|Hot Springs, Arkansas, Hot Springs, Arkansas, 71913, United States|Encinitas, California, Encinitas, California, 92024, United States|Fountain Valley, California, Fountain Valley, California, 92708, United States|Lomita, California, Lomita, California, 90717, United States|Miami, Florida, Miami, Florida, 33173, United States|Tampa, Florida, Tampa, Florida, 33613, United States|Clarksville, Indiana, Clarksville, Indiana, 47129, United States|Troy, Michigan, Troy, Michigan, 48084, United States|Warren, Michigan, Warren, Michigan, 48192, United States|New York, New York, New York, New York, 11211, United States|Wilmington, North Carolina, Wilmington, North Carolina, 28405, United States|Bexley, Ohio, Bexley, Ohio, 43209, United States|Mason, Ohio, Mason, Ohio, 45040, United States|Mayfield Heights, Ohio, Mayfield Heights, Ohio, 44124, United States|Portland, Oregon, Portland, Oregon, 97225, United States|Austin, Texas, Austin, Texas, 78759, United States|Frisco, Texas, Frisco, Texas, 75034, United States|Houston, Texas, Houston, Texas, 77056, United States|San Antonio, Texas, San Antonio, Texas, 78213, United States|Jordan, Utah, Jordan, Utah, 84095, United States|Spokane, Washington, Spokane, Washington, 99202, United States"
NCT06012240,A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06012240,NO,Alopecia Areata,DRUG: Upadacitinib|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE3,"Total Skin and Beauty Dermatology Center /ID# 259539, Birmingham, Alabama, 35205, United States|Advanced Research Associates - Glendale /ID# 259108, Glendale, Arizona, 85308, United States|Southwest Skin Specialists /ID# 258234, Phoenix, Arizona, 85018-3953, United States|Alliance Dermatology and Mohs Center /ID# 258111, Phoenix, Arizona, 85032, United States|Johnson Dermatology Clinic /ID# 259103, Fort Smith, Arkansas, 72916-6103, United States|Joseph Raoof Md,Inc /Id# 258031, Encino, California, 91436, United States|First OC Dermatology /ID# 259220, Fountain Valley, California, 92708, United States|University of California Irvine /ID# 259096, Irvine, California, 92697-1385, United States|Dermatology Research Associates /ID# 258033, Los Angeles, California, 90045, United States|Integrative Skin Science and Research /ID# 258114, Sacramento, California, 95815, United States|University of California Davis Health /ID# 258112, Sacramento, California, 95817, United States|Clinical Trials Research Institute /ID# 258021, Thousand Oaks, California, 91320-2130, United States|Skin Care Research Boca Raton /ID# 258012, Boca Raton, Florida, 33486-2269, United States|Apex Clinical Trials /ID# 259205, Brandon, Florida, 33511, United States|Florida Academic Dermatology Center /ID# 259353, Coral Gables, Florida, 33134-5755, United States|Revival Research /ID# 259213, Doral, Florida, 33122-1902, United States|Skin Care Research - Hollywood /ID# 259210, Hollywood, Florida, 33021-6748, United States|GSI Clinical Research, LLC /ID# 259352, Margate, Florida, 33063, United States|Life Clinical Trials /ID# 259358, Margate, Florida, 33063, United States|Lenus Research and Medical Group /ID# 259356, Miami, Florida, 33172, United States|International Clinical Research - Sanford /ID# 259547, Sanford, Florida, 32771, United States|Advanced Clinical Research Institute /ID# 259204, Tampa, Florida, 33607, United States|Avita Clinical Research /ID# 258011, Tampa, Florida, 33613-1825, United States|Cleaver Medical Group Dermatology /ID# 259801, Dawsonville, Georgia, 30534, United States|Marietta Dermatology /ID# 259818, Marietta, Georgia, 30060, United States|U.S. Dermatology Partners Leawood /ID# 259203, Leawood, Kansas, 66211-1453, United States|MetroBoston Clinical Partners /ID# 259559, Boston, Massachusetts, 02135-3511, United States|Lahey Hospital & Medical Center /ID# 260484, Burlington, Massachusetts, 01805, United States|Great Lakes Research Group - Bay City /ID# 259100, Bay City, Michigan, 48706, United States|Hamzavi Dermatology - Canton /ID# 260115, Canton, Michigan, 48187, United States|Clin Res Inst of Michigan, LLC /ID# 259802, Chesterfield, Michigan, 48047, United States|Clarkston Dermatology /ID# 258018, Clarkston, Michigan, 48346, United States|Henry Ford Medical Center - New Center One /ID# 258067, Detroit, Michigan, 48202-3046, United States|M Health Fairview University of Minnesota Medical Center - East Bank /ID# 260122, Minneapolis, Minnesota, 55455, United States|Minnesota Clinical Study Center /ID# 259218, New Brighton, Minnesota, 55112, United States|Dermatology and Skin Center of Lees Summit /ID# 259206, Lee's Summit, Missouri, 64064-2301, United States|Physician Research Collaboration, LLC /ID# 259354, Lincoln, Nebraska, 68516, United States|Skin Specialists, PC /ID# 259237, Omaha, Nebraska, 68144, United States|Skin Cancer and Dermatology Institute - Reno /ID# 259208, Reno, Nevada, 89509, United States|Schweiger Dermatology, P.C. /ID# 259531, Verona, New Jersey, 07044-2946, United States|Icahn School of Medicine at Mount Sinai /ID# 259808, New York, New York, 10029, United States|Schweiger Dermatology, P.C. /ID# 258007, Verona, New York, 07044-2946, United States|Remington-Davis Clinical Research /ID# 258106, Columbus, Ohio, 43215, United States|Dermatologists of Southwest Ohio, Inc /ID# 260116, Mason, Ohio, 45040-4520, United States|Oregon Dermatology and Research Center /ID# 258243, Portland, Oregon, 97210, United States|Oregon Medical Research Center /ID# 258107, Portland, Oregon, 97223, United States|Medical University of South Carolina /ID# 259828, Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC /ID# 259552, Murfreesboro, Tennessee, 37130-2450, United States|Arlington Research Center, Inc /ID# 258028, Arlington, Texas, 76011, United States|Bellaire Dermatology Associates /ID# 259360, Bellaire, Texas, 77401, United States|U.S. Dermatology Partners - Cedar Park /ID# 259367, Cedar Park, Texas, 78613, United States|Dermatology Treatment and Research Center /ID# 259357, Dallas, Texas, 75230, United States|Modern Research Associates, PLLC /ID# 259349, Dallas, Texas, 75231, United States|Reveal Research Institute, Dallas /ID# 259361, Dallas, Texas, 75235-2519, United States|Center for Clinical Studies - Houston - Northwest Freeway /ID# 258036, Houston, Texas, 77065, United States|Progressive Clinical Research /ID# 259365, San Antonio, Texas, 78229, United States|Complete Dermatology /ID# 258025, Sugar Land, Texas, 77479-3794, United States|Buenos Aires Skin /ID# 258297, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1055, Argentina|Instituto de Neumonologia y Dermatologia /ID# 258640, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Psoriahue Med Interdisciplinar /ID# 258641, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 258639, Buenos Aires, 1061, Argentina|Instituto de Investigaciones Clinicas Córdoba /ID# 260244, Cordoba, 5000, Argentina|Holdsworth House Medical Practice /ID# 258571, Darlinghurst, New South Wales, 2010, Australia|St George Dermatology & Skin Cancer Centre /ID# 258567, Kogarah, New South Wales, 2217, Australia|Cornerstone Dermatology /ID# 258769, Coorparoo, Queensland, 4151, Australia|Veracity Clinical Research /ID# 258566, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute Inc /ID# 258570, Carlton, Victoria, 3053, Australia|Sinclair Dermatology - Melbourne /ID# 258565, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital /ID# 258770, Parkville, Victoria, 3050, Australia|Fremantle Dermatology /ID# 260207, Fremantle, Western Australia, 6160, Australia|Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 258045, Porto Alegre, Rio Grande Do Sul, 90020-090, Brazil|Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 258105, Campinas, Sao Paulo, 13034-685, Brazil|Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 258750, Rio de Janeiro, 20241-180, Brazil|Hospital Alemao Oswaldo Cruz /ID# 258104, Sao Paulo, 01323-020, Brazil|Diagnostic Consultative Center Aleksandrovska /ID# 257049, Sofiya, Sofia, 1431, Bulgaria|UMHAT Sveti Georgi /ID# 257548, Plovdiv, 4002, Bulgaria|Ambulatory for Specialized Medical Care for skin and venereal diseases /ID# 257047, Sofia, 1407, Bulgaria|XX Diagnostic consultative center Sofia EOOD /ID# 257273, Sofiya, 1618, Bulgaria|UMHAT Professor Stoyan Kirkovich /ID# 257051, Stara Zagora, 6000, Bulgaria|Dr. Chih-ho Hong Medical Inc. /ID# 258814, Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research /ID# 258819, Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center /ID# 258820, Barrie, Ontario, L4M 7G1, Canada|Lynde Institute for Dermatology /ID# 258815, Markham, Ontario, L3P 1X2, Canada|JRB Research /ID# 259248, Ottawa, Ontario, K1H 7X3, Canada|SKiN Centre for Dermatology /ID# 258813, Peterborough, Ontario, K9J 5K2, Canada|Medicor Research Inc /ID# 258810, Sudbury, Ontario, P3C 1X3, Canada|Private Practice - Dr. Kim Papp Clinical Research /ID# 259249, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc. /ID# 258812, Montréal, Quebec, H2X 2V1, Canada|Centre de Recherche dermatologique du Quebec Metropolitain /ID# 258811, Québec, Quebec, G1V 4X7, Canada|Centro Medico Skin Med SPA /ID# 259314, Las Condes, Region Metropolitana Santiago, 7580206, Chile|Clinica Dermacross /ID# 259311, Vitacura, Region Metropolitana Santiago, 7640881, Chile|Centro Internacional de Estudios Clinicos - CIEC /ID# 259312, Santiago, 8420383, Chile|Beijing Chaoyang Hospital,Capital Medical University /ID# 258912, Beijing, Beijing, 100020, China|China-Japan Friendship Hospital /ID# 258941, Beijing, Beijing, 100029, China|The First Affiliated Hospital, Sun Yat-sen University /ID# 257367, Guangzhou, Guangdong, 510080, China|Dermatology Hospital of Southern Medical University /ID# 257118, Guangzhou, Guangdong, 510091, China|The First Affiliated Hospital of Guangzhou Medical University /ID# 258663, Guangzhou, Guangdong, 510163, China|Zhujiang Hospital of Southern Medical University /ID# 258485, Guangzhou, Guangdong, 510280, China|Shenzhen People's Hospital /ID# 258208, Shenzhen, Guangdong, 518020, China|Shenzhen Second People's Hospital /ID# 258060, Shenzhen, Guangdong, 518039, China|Renmin Hospital of Wuhan University /ID# 260260, Wuhan, Hubei, 430060, China|Dermatology Hospital of Jiangxi Provincial /ID# 259488, Nanchang, Jiangxi, 330030, China|The First Hospital of Jilin University /ID# 257496, Changchun, Jilin, 130021, China|Second Affiliated Hospital of Xian Jiaotong University /ID# 257497, Xi'an, Shaanxi, 710004, China|Huashan Hospital, Fudan University /ID# 257758, Shanghai, Shanghai, 200040, China|First Affiliated Hospital of Shanxi Medical University /ID# 259647, Taiyuan, Shanxi, 030001, China|Chengdu Second Municipal People's Hospital /ID# 259492, Chengdu, Sichuan, 610017, China|West China Hospital, Sichuan University /ID# 259560, Chengdu, Sichuan, 610041, China|Tianjin Medical University General Hospital /ID# 259525, Tianjin, Tianjin, 300052, China|The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 257260, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 257119, Hangzhou, Zhejiang, 310020, China|The First Affiliated Hospital of Wenzhou Medical University /ID# 257739, Wenzhou, Zhejiang, 325000, China|The Second Affiliated Hospital of Chongqing Medical University /ID# 260254, Chongqing, 400010, China|HCL - Hopital Edouard Herriot /ID# 256983, Lyon, Rhone, 69003, France|CHRU de Brest - Hopital Morvan /ID# 256979, Brest, 29200, France|Centre de Sante Sabouraud /ID# 257213, Paris, 75010, France|CHU Toulouse - Hopital Larrey /ID# 256980, Toulouse, 31400, France|Universitaetsklinikum Duesseldorf /ID# 257307, Düsseldorf, Nordrhein-Westfalen, 40225, Germany|Universitaetsklinikum Muenster /ID# 257306, Muenster, Nordrhein-Westfalen, 48149, Germany|Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 257305, Lübeck, Schleswig-Holstein, 23538, Germany|Fachklinik Bad Bentheim /ID# 257741, Bad Bentheim, 48455, Germany|Charité Universitätsmedizin Berlin - Campus Mitte /ID# 257310, Berlin, 10117, Germany|Klinikum rechts der Isar /ID# 257609, Munich, 81675, Germany|DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 257469, Debrecen, 4031, Hungary|Bagoly Egeszseghaz (Meditres Kft.) /ID# 258032, Kecskemet, 6000, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 257468, Pecs, 7624, Hungary|Rambam Health Care Campus /ID# 257769, Haifa, H_efa, 3525408, Israel|The Chaim Sheba Medical Center /ID# 257770, Ramat Gan, Tel-Aviv, 5265601, Israel|Tel Aviv Sourasky Medical Center /ID# 257771, Tel Aviv, Tel-Aviv, 6423906, Israel|Hadassah Medical Center-Hebrew University /ID# 257946, Jerusalem, Yerushalayim, 91120, Israel|Rabin Medical Center /ID# 257772, Haifa, 4941492, Israel|Kurume University Hospital /ID# 257255, Kurume-shi, Fukuoka, 830-0011, Japan|Kitasato University Hospital /ID# 257285, Sagamihara-shi, Kanagawa, 252-0375, Japan|Niigata University Medical & Dental Hospital /ID# 259425, Niigata-shi, Niigata, 951-8520, Japan|Osaka Metropolitan University Hospital /ID# 257256, Osaka-shi, Osaka, 545-8586, Japan|Hamamatsu University Hospital /ID# 257253, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Tokyo Medical University Hospital /ID# 258132, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamaguchi University Hospital /ID# 257252, Ube-shi, Yamaguchi, 755-8505, Japan|Kyorin University - Mitaka Campus /ID# 257283, Mitaka, 181-8611, Japan|Pusan National University Hospital /ID# 257910, Busan, Busan Gwang Yeogsi, 49241, Korea, Republic of|Kyungpook National University Hospital /ID# 257908, 중구, Daegu Gwang Yeogsi, 41944, Korea, Republic of|Seoul National University Bundang Hospital /ID# 257906, Seongnam-si, Gyeonggido, 13620, Korea, Republic of|Inha University Hospital /ID# 257904, Incheon, Incheon Gwang Yeogsi, 21565, Korea, Republic of|Seoul National University Hospital /ID# 257903, Seoul, Seoul Teugbyeolsi, 03080, Korea, Republic of|Konkuk University Medical Center /ID# 257900, Seoul, Seoul Teugbyeolsi, 05030, Korea, Republic of|Kyung Hee University Hospital at Gangdong /ID# 257907, Seoul, Seoul Teugbyeolsi, 05278, Korea, Republic of|Hallym University Kangdong Sacred Heart Hospital /ID# 257905, Seoul, 05355, Korea, Republic of|Greenlane Clinical Centre /ID# 258563, Epsom, Auckland, 1051, New Zealand|Aotearoa Clinical Trials /ID# 258562, Auckland, 1640, New Zealand|Clinical Trials New Zealand /ID# 258564, Hamilton, 3204, New Zealand|P3 Research Ltd /ID# 259846, Wellington, 6021, New Zealand|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno Badawczy /ID# 257534, Krakow, Malopolskie, 30-002, Poland|Klinika Osipowicz & Turkowski sp.z.o.o /ID# 257598, Warszawa, Mazowieckie, 00-716, Poland|Centrum Medyczne ALL-MED Badania Kliniczne /ID# 257590, Cracow, 30-033, Poland|Unidade Local de Saude de Almada-Seixal, EPE /ID# 257425, Almada, 2805-267, Portugal|Hospital CUF Descobertas /ID# 257419, Lisboa, 1998-018, Portugal|Unidade Local de Saude de Santo Antonio, E.P.E. /ID# 258554, Porto, 4099-003, Portugal|Santa Cruz Behavioral (SCB) Research Center /ID# 259350, Bayamon, 00961-6910, Puerto Rico|Dr. Samuel Sanchez PSC /ID# 259359, Caguas, 00727, Puerto Rico|Clinical Research Puerto Rico /ID# 259355, San Juan, 00909-1711, Puerto Rico|GCM Medical Group PSC /ID# 258013, San Juan, 00917-3104, Puerto Rico|Mindful Medical Research /ID# 260113, San Juan, 00918-3756, Puerto Rico|Hospital Universitario Reina Sofia /ID# 257035, Córdoba, Cordoba, 14004, Spain|Hospital Universitario de Fuenlabrada /ID# 257334, Fuenlabrada, Madrid, 28942, Spain|Hospital Santa Creu i Sant Pau /ID# 257034, Barcelona, 08041, Spain|Hospital Universitario Dr. Peset /ID# 257036, Valencia, 46017, Spain|Kaohsiung Chang Gung Memorial Hospital /ID# 258726, Kaohsiung City, Kaohsiung, 833, Taiwan|National Taiwan University Hospital /ID# 257407, Taipei City, Taipei, 100, Taiwan|National Cheng Kung University Hospital /ID# 257409, Tainan, 704, Taiwan|Taipei Veterans General Hosp /ID# 257413, Taipei, 11217, Taiwan|Velocity Clinical Research Ltd /ID# 257925, High Wycombe, Buckinghamshire, HP11 2QW, United Kingdom|Oxford University Hospitals NHS Foundation Trust /ID# 257948, Oxford, Oxfordshire, OX3 9DU, United Kingdom|University Hospitals Sussex NHS Foundation Trust /ID# 257912, Worthing, West Sussex, BN11 2DH, United Kingdom|Gloucestershire Royal Hospital /ID# 257953, Gloucester, GL1 3NN, United Kingdom|London North West University Healthcare NHS Trust /ID# 257914, Harrow, HA1 3UJ, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust /ID# 259128, London, SW10 9NH, United Kingdom|Northern Care Alliance NHS Group /ID# 257952, Salford, M6 8HD, United Kingdom"
NCT05803070,Topical Cetirizine in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT05803070,NO,Alopecia Areata,DRUG: Topical Cetirizine 1 %|DRUG: Topical betamethasone valerate 0.1%,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT06399783,Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06399783,NO,Alopecia Areata,DRUG: Simvastatin|DRUG: Mometasone Furoate|PROCEDURE: Fractional CO2 laser,ALL,"CHILD, ADULT",PHASE4,"Assiut university, Assiut, 73333, Egypt"
NCT04006457,Long-Term PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04006457,NO,Alopecia Areata,"DRUG: PF-06651600|BIOLOGICAL: Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine|BIOLOGICAL: Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"The University of Alabama at Birmingham Hosptial Outreach Lab, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States|Mosaic Dermatology, Beverly Hills, California, 90211, United States|Univ of California, Irvine, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Dermatology Specialists Inc., Murrieta, California, 92562, United States|University of California, San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Aurora, Colorado, 80045, United States|University of Colorado Hospital Outpatient Pavilion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Investigational Drug Services, New Haven, Connecticut, 06511, United States|Yale School of Medicine, Yale Center for Clinical Investigations, New Haven, Connecticut, 06519, United States|Yale School of Medicine, Yale Center for Clinical Investigation, New Haven, Connecticut, 06519, United States|Medstar Georgetown University Hospital - Department of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Georgetown University Hospital-Dept of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Washington Hospital Center-Claude Nogay Research Pharmacy, Washington, District of Columbia, 20010, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Medstar Georgetown University Hospital - Department of Pediatrics, Washington, District of Columbia, 20016, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Velocity Clinical Research - Boise, Meridian, Idaho, 83642, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Medicine Diagnostic Testing Center, Chicago, Illinois, 60611, United States|Northwestern Medicine, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital Investigational Drug Service Pharmacy, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|Summit Dermatology and Aesthetic Surgery (in c/o TrialSpark, Inc), Oakbrook Terrace, Illinois, 60181, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|Northshore University HealthSystem/Dermatology, Skokie, Illinois, 60077, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Medstar Georgetown University Hospital - Department of Dermatology, Chevy Chase, Maryland, 20815, United States|Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS), Boston, Massachusetts, 02114, United States|University of Minnesota Clinical Research Unit (CRU), Minneapolis, Minnesota, 55455, United States|University of Minnesota Lillehei Clinical Research Unit (LCRU), Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Investigational Drug Services Attn: Darlette Luke, Minneapolis, Minnesota, 55455, United States|Skin Specialists PC, Omaha, Nebraska, 68144, United States|Schweiger Dermatology, P.C., Verona, New Jersey, 07044, United States|NYU School of Medicine, The Ronald O. Perelman Department of Dermatology, New York, New York, 10016, United States|Pura Dermatology (in c/o TrialSpark, Inc), New York, New York, 10018, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UNC CTRC, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, Investigational Drug Service, Chapel Hill, North Carolina, 27514, United States|UNC Dermatology and Skin Cancer Center, Chapel Hill, North Carolina, 27516, United States|UNC Dermatology Clinical Trials Unit, Chapel Hill, North Carolina, 27516, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|The University of Texas Health Science Center at Houston, Bellaire, Texas, 77401, United States|Tamjidi Skin Institute (in c/o TrialSpark, Inc), Vienna, Virginia, 22182, United States|CINME Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Psoriahue Medicina Interdisciplinaria, Caba, C1425DKG, Argentina|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|St George Dermatology & Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Royal Melbourne Hospital, Melbourne Health, Parkville, Victoria, 3050, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Royal Melbourne Hospital, Melbourne Health, Parkville, Victoria, 3052, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Eastern Canada Cutaneous Research Associates Ltd., Halifax, Nova Scotia, B3H 1Z2, Canada|Guenther Research Inc, London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4C 9M7, Canada|Medicor Research Inc, Sudbury, Ontario, P3A 1W8, Canada|Medicor Research Inc, Sudbury, Ontario, P3C 1X3, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|Research Toronto, Toronto, Ontario, M4W 2N2, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Quebec, G1V 4X7, Canada|Centro Medico Skin Med, Santiago, LAS Condes, 7580206, Chile|Centro Internacional de Estudios Clinicos - CIEC, Santiago, Recoleta, 8420383, Chile|Medical Skin Center, Vina del Mar, Valparaiso, 2530900, Chile|Clinica Dermacross S.A., Santiago, Vitacura, 7640881, Chile|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China|The University of Hong Kong - Shenzhen Hospital, Shenzhen, Guangdong, 518053, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, China|Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, 200025, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Fundacion Centro de Investigacion Clinica CIC, Medellin, Antioquia, 050001, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellin, Antioquia, 050010, Colombia|Centro de Investigacion en Reumatologia y Especialidades Medicas S.A.S, CIREEM S.A.S, Bogota D.C., 110221, Colombia|DERMAMEDICA s.r.o., Nachod, 547 01, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Clintrial s.r.o., Praha 10, 100 00, Czechia|Sanatorium profesora Arenbergera, Praha 1, 110 00, Czechia|Fachklinik Bad Bentheim, Bad Bentheim, Lower Saxony, 48455, Germany|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Emovis GmbH, Berlin, 10629, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|University Hospital Frankfurt, Frankfurt am Main, 60590, Germany|University Hospital Schleswig-Holstein, Luebeck, 23538, Germany|University Hospital Muenster, Muenster, 48149, Germany|Nagoya City University Hospital, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai, Miyagi, 980-8574, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, 136-0075, Japan|Kyorin University Hospital, Mitaka-shi, Tokyo, 181-8611, Japan|Osaka Metropolitan University Hospital, Osaka, 545-8586, Japan|Tokyo Medical University Hospital, Tokyo, 160-0023, Japan|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Sociedad de Metabolismo y Corazon S.C., Veracruz, 91900, Mexico|Hospital D Maria, Veracruz, 91910, Mexico|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|McBk S.C., Grodzisk Mazowiecki, 05-825, Poland|Centermed Krakow Sp.z o.o., Krakow, 31-530, Poland|Dermoklinika Centrum Medyczne s.c. M.Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|RCMed Oddzial Warszawa, Warszawa, 00-892, Poland|Magdalena Opadczuk Carpe Diem Centrum Medycyny Estetycznej, Warszawa, 02-661, Poland|ETG Warszawa, Warszawa, 02-793, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej we Wroclawiu, Wroclaw, 50-220, Poland|Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spółka Partnerska, Wroclaw, 50-566, Poland|Centrum Medyczne OPOROW, Wroclaw, 52-416, Poland|State Budgetary Healthcare Institution ""Chelyabinsk Regional Clinical Dermatovenerologic Dispensary"", Chelyabinsk, 454092, Russian Federation|University Clinic of Kirov SMU, Kirov, 610035, Russian Federation|Clinical Medical Center of Moscow State University of Medicine and Dentistry, Moscow, 111398, Russian Federation|Federal State Autonomous Institution ""National Medical Research Centre of Children's' Health"", Moscow, 119991, Russian Federation|State Budgetary Institution of the Rostov Region ""Dermatovenerologic Dispensary"", Rostov-on-Don, 344002, Russian Federation|Limited Liability Company ""Pierre Volkenshtein Skin Diseases Clinic"", Saint Petersburg,, 191123, Russian Federation|Limited Liability Company ""Centre Vitiligo"" (""Centre Vitiligo"" LLC), Saint Petersburg, 191123, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""Dermatovenerologic Dispensary No. 10 -, Saint Petersburg, 194021, Russian Federation|State Autonomous Healthcare Institution of the Yaroslavl Region ""Clinical Emergency Hospital, Yaroslavl, 150003, Russian Federation|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario La Paz: Servicio de Farmacia, Madrid, 28046, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Chung-Shan Medical University Hospital, Taichung, R.o.c., 40201, Taiwan|Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, 83301, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, 23561, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital, Taoyuan City, 333, Taiwan|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, SO14 0YG, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, SO16 6YD, United Kingdom|University Hospitals Sussex NHS Foundation Trust (UHSussex), Brighton, BN2 1ES, United Kingdom|NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|Guy's and St Thomas Hospitals NHS Foundation Trust, St Thomas Hospital, London, SE1 7EH, United Kingdom|Guy's and St Thomas' Hospitals NHS Foundation Trust, St Thomas' Hospital, London, SE1 7EH, United Kingdom|Guy's and St Thomas' Hospitals NHS Foundation Trust, Guy's Hospital, London, SE1 9RT, United Kingdom"
NCT03800979,Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT03800979,YES,Alopecia Areata,DRUG: Tofacitinib,ALL,ADULT,PHASE4,"Institute of Dermatology, Bangkok, Thailand"
NCT03847441,Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03847441,NO,Alopecia Areata,DRUG: Calcipotriol|DEVICE: Narrow Band UVB|DIAGNOSTIC_TEST: vitamin D3 level,ALL,"CHILD, ADULT",NA,"Aswan University Hospital, Aswan, 81528, Egypt"
NCT05885269,Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata,https://clinicaltrials.gov/study/NCT05885269,NO,Alopecia Areata,DRUG: Group A applied topical Clobetasol Propionate|DRUG: Group B applied topical Tacrolimus,ALL,ADULT,PHASE1,"Danyal Sajjad, Abbottabad, Khyber Pakhtunkhwa, Pakistan"
NCT05485571,Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05485571,NO,Alopecia Areata,DEVICE: derma pen,ALL,ADULT,NA,"Sohag University Hospital, Sohag, Egypt"
NCT05910138,Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05910138,NO,Alopecia Areata,DIAGNOSTIC_TEST: Serum Interlukin-15|DIAGNOSTIC_TEST: Serum Interlukin-21,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Sohag University hospitals, Sohag, Egypt"
NCT04660786,Intralesional Vitamin D in Alopecia Areata,https://clinicaltrials.gov/study/NCT04660786,NO,Alopecia Areata,DRUG: triamcinolone acetonide|DRUG: vitamin D,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Faculty of Medicine, Alexandria, 21521, Egypt"
NCT02691117,Topical Garlic Concentrate for Alopecia Areata in Children,https://clinicaltrials.gov/study/NCT02691117,NO,Alopecia Areata,DRUG: garlic concentrate,ALL,"CHILD, ADULT",PHASE3,"Th Hospital for Sick Children, Toronto, Ontario, M5G1X8, Canada"
NCT04412148,Modified SALT Score for Alopecia Areata,https://clinicaltrials.gov/study/NCT04412148,NO,Alopecia Areata,DRUG: Triamcinolone Acetonide|OTHER: saline,ALL,ADULT,PHASE4,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, Egypt"
NCT00167102,Alefacept in Patients With Severe Scalp Alopecia Areata,https://clinicaltrials.gov/study/NCT00167102,YES,Alopecia Areata,DRUG: Alefacept,ALL,"ADULT, OLDER_ADULT",NA,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT05017454,Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids,https://clinicaltrials.gov/study/NCT05017454,NO,Alopecia Areata,DRUG: the optimized sodium valproate-loaded nanospanlastic dispersion|DRUG: mometasone furoate lotion,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,"Kasralainy Hospital, Dermatology Department, Cairo, Egypt"
NCT02599129,A Study of Secukinumab for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02599129,YES,Alopecia Areata,DRUG: Secukinumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT04556734,Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04556734,YES,Alopecia Areata,DRUG: Etrasimod|DRUG: Etrasimod|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigate MD, Scottsdale, Arizona, 85255, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|University of California,Irvine, Irvine, California, 92697, United States|Prospect Optometry, Lomita, California, 90717, United States|Torrance Clinical Research Institute,Inc., Lomita, California, 90717, United States|Yale Eye Center, New Haven, Connecticut, 06511, United States|Yale Investigational Drug Services, New Haven, Connecticut, 06511, United States|Yale Center for Clinical Investigation, New Haven, Connecticut, 06519, United States|Yale New Haven Hospital Department of Respiratory Care, New Haven, Connecticut, 06519, United States|Advanced Sleep & Respiratory Institute, PA, Daytona Beach, Florida, 32117, United States|International Eye Associates, Ormond Beach, Florida, 32174, United States|Leavitt Medical Associates of Florida d/ba Ameriderm Research, Ormond Beach, Florida, 32174, United States|Advanced Clinical Research Institute, Tampa, Florida, 33607, United States|Advanced Medical Research PC, Sandy Springs, Georgia, 30328, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Eye Surgeons of Indiana, Indianapolis, Indiana, 46260, United States|Magnante Eye Care (Ophthalmological Assessments), Lafayette, Indiana, 47905, United States|Physicians Research Group (Administrative Office Location), Noblesville, Indiana, 46060, United States|Physicians Research Group, West Lafayette, Indiana, 47906, United States|Randall Dermatology, PC, West Lafayette, Indiana, 47906, United States|Lawrence J. Green, MD LLC, Rockville, Maryland, 20850, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|NYC Retina- Manhattan, New York, New York, 10003, United States|Bobby Buka MD, PC, New York, New York, 10012, United States|Rochester Ophthalmological Group, Rochester, New York, 14623, United States|Skin Search of Rochester, Inc., Rochester, New York, 14623, United States|WDC Cosmetic and Research, PLLC, Wilmington, North Carolina, 28405, United States|NW Dermatology Institute, Portland, Oregon, 97210, United States|UPMC Department of Dermatology, Pittsburgh, Pennsylvania, 15213, United States|UPMC Eye Center, Pittsburgh, Pennsylvania, 15213, United States|International Clinical Research - Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research, PA, San Antonio, Texas, 78213, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|PRINCIPLE RESEARCH SOLUTIONS (pulmonary function testing), Spokane, Washington, 99204, United States|SPOKANE EYE CLINIC (OCT and optical exam, Spokane, Washington, 99204, United States|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Laser Rejuvenation Clinics Edmonton D.T. Inc., Edmonton, Alberta, T5J 3S9, Canada|Innovaderm Research, Montreal, Quebec, H2X 2V1, Canada"
NCT05926882,"Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT05926882,NO,Alopecia Areata,DRUG: Apremilast 30mg,ALL,"ADULT, OLDER_ADULT",PHASE4,"JPMC, Karachi, Sindh, Pakistan"
NCT05861401,Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05861401,NO,Alopecia Areata,GENETIC: Janus Kinase 1 and 2,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Sohag University hospitals, Sohag, Egypt"
NCT01802177,Excimer Light for Alopecia Areata,https://clinicaltrials.gov/study/NCT01802177,NO,Alopecia Areata,PROCEDURE: UVB excimer light,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT01736007,Childhood Alopecia Areata Study Using the 308-nm Excimer Laser,https://clinicaltrials.gov/study/NCT01736007,NO,Alopecia Areata,DEVICE: 308-nm excimer laser to alopecia patch|DEVICE: Liquid light guide tip on laser,ALL,CHILD,NA,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States"
NCT04517864,PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA,https://clinicaltrials.gov/study/NCT04517864,YES,Alopecia Areata,DRUG: PF-06651600|DRUG: Placebo,ALL,ADULT,PHASE2,"Marvel Clinical Research 002, LLC, Huntington Beach, California, 92647, United States|University of California, Irvine, Irvine, California, 92697, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Skin Care Research, Hollywood, Florida, 33021, United States|Kendall Adkisson, MD - Intracoastal Dermatology, Jacksonville, Florida, 32224, United States|Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, 32256, United States|Y&L Advance Health Care Inc., d/b/a Elite Clinical Research, Miami, Florida, 33144, United States|BRCR Medical Center Inc, Miramar, Florida, 33027, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Orlando, Florida, 32801, United States|Orlando Dermatology & Skin Cancer Surgery Center, Oviedo, Florida, 32765, United States|USF Health Morsani Center For Advanced Healthcare, Tampa, Florida, 33612, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|NorthShore University HealthSystem Dermatology Clinic, Skokie, Illinois, 60077, United States|Washington University School of Medicine-Dermatology, Saint Louis, Missouri, 63108, United States|University of New Mexico Department of Dermatology, Albuquerque, New Mexico, 87102, United States|University of New Mexico Clinical & Translational Sciences Center, Albuquerque, New Mexico, 87106, United States|Stony Brook Dermatology, Stony Brook, New York, 11790, United States|M3 Wake Research, Inc., Raleigh, North Carolina, 27612, United States|Tekton Research, Inc., Austin, Texas, 78745, United States|Center for Clinical Studies, LTD. LLP, Houston, Texas, 77004, United States|Summit Clinical Research, LLC, Franklin, Virginia, 23851, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|Eastern Health - Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Sima Recherche, Verdun, Quebec, H4G 3E7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W4R4, Canada|Niepubliczny Zaklad Opieki Zdrowotnej Specjalistyczny Osrodek Dermatologiczny ""DERMAL"", Bialystok, 15-453, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|AWP Klinika Dermatologii Pod Fortem Anna Wojas-Pelc, Krakow, 31-302, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|RCMed Oddzial Warszawa, Warszawa, 00-892, Poland|MTZ Clinical Research Sp. z o.o, Warszawa, 02-106, Poland|MTZ Clinical Research Powered by Pratia, Warszawa, 02-172, Poland|Przychodnia przy ul. Lowieckiej, Wroclaw, 50-220, Poland|Centrum Medyczne Matusiak, Wrocław, 50-566, Poland"
NCT04964349,Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04964349,NO,Alopecia Areata,DRUG: Corticosteroids Acting Locally,ALL,"CHILD, ADULT",EARLY_PHASE1,"Alazhar faculty of meidicine, Cairo, Egypt"
NCT05414266,Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata,https://clinicaltrials.gov/study/NCT05414266,NO,Alopecia Areata,DRUG: Placebo|DRUG: SADBE 5%,ALL,"CHILD, ADULT",EARLY_PHASE1,"The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States"
NCT05278858,Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05278858,YES,Alopecia Areata,COMBINATION_PRODUCT: MedJet Device with intralesional triamcinolone,ALL,CHILD,PHASE4,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States"
NCT00176982,"Plaquenil for Alopecia Areata, Alopecia Totalis",https://clinicaltrials.gov/study/NCT00176982,NO,Alopecia Areata,DRUG: Hydroxychloroquine,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|State University of New York at Stony Brook, Stonybrook, New York, 11790, United States"
NCT05587257,Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05587257,NO,Alopecia Areata,DEVICE: Fractional CO2 laser|DEVICE: Derma pen|DRUG: Niosome minoxidil|DRUG: Minoxidil Topical Spray,ALL,"CHILD, ADULT",NA,
NCT06327581,Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06327581,NO,Alopecia Areata,DRUG: Lactic Acid|DRUG: vit D|DRUG: Triamcinolone Acetonide|DRUG: Saline,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Rana Ehab, Zagazig, 44519, Egypt"
NCT06104839,Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06104839,NO,Alopecia Areata,DRUG: NXC736|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT05368103,Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05368103,NO,Alopecia Areata,BIOLOGICAL: Daxdilimab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|First OC Dermatology Research, Inc., Fountain Valley, California, 92708, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|DS Research, Louisville, Kentucky, 40241, United States|Progressive Clinical Research, P.A., San Antonio, Texas, 78213, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Dr Dusan Sajic Medicine Professional Corporation, Guelph, Ontario, N1L 0B7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2,, Canada|Innovaderm Research, Montréal, Quebec, H2X 2V1, Canada|Centre de Recherche Saint-Louis (Quebec), Quebec, G1W 4R4, Canada"
NCT04793945,Excimer Light and Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04793945,NO,Alopecia Areata,COMBINATION_PRODUCT: topical steroid and 308nm-Excimer light therapy,ALL,"CHILD, ADULT",PHASE4,
NCT04797650,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2),https://clinicaltrials.gov/study/NCT04797650,YES,Alopecia Areata,DRUG: CTP-543 matching placebo|DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Alliance Dermatology & Mohs Center, Phoenix, Arizona, 85032, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|University of Miami Hospital, Miami, Florida, 33124, United States|Floridian Research Institute LLC, Miami, Florida, 33145, United States|MetroBoston Clinical Partners, LLC, Brighton, Massachusetts, 02135, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, 48087, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Galen Research, Chesterfield, Missouri, 63005, United States|Vivida Dermatology, Las Vegas, Nevada, 89148, United States|The Dermatology Group P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center - Department of Dermatology, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|Oregon Medical Research, Portland, Oregon, 97223, United States|Velocity Clinical Research - Providence, Warwick, Rhode Island, 02886, United States|The Skin Wellness Center, Knoxville, Tennessee, 37922, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Elixir Research Group, Houston, Texas, 77077, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Velocity Clinical Research/Gateway, Salt Lake City, Utah, 84101, United States|Velocity Clinical Research/Swinyer-Woseth Dermatology, Salt Lake City, Utah, 84117, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|The Rector and Visitors of the University of Virginia, Charlottesville, Virginia, 22903, United States|Care Clinic Ltd., Red Deer, Alberta, T4N6V7, Canada|Medical Arts Health Research Group, Kelowna, British Columbia, V1Y 4N7, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X1Y9, Canada|North Bay Dermatology Centre, North Bay, Ontario, P1B 3Z7, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B1A5, Canada|Centre de Recherche Saint-Louis, Quebec, G1W4R4, Canada|Centre de Recherche Dermatologique du Quebec Metropolitan, Quebec, L4B1A5, Canada|Centre Hospitalier Universitaire de Nice - Hôpital Archet 2, Nice, Alpes-maritimes, 06202 CEDEX 3, France|Chru de Brest - Hôpital Morvan, Brest, Finestère, 29609 CEDEX, France|Universitaetsklinikum Tübingen, Tübingen, Baden-württemberg, 72076, Germany|Klinikum Rechts Der Isar, Technische Universität München, Munich, Bayern, 80802, Germany|Universitätsklinikum Frankfurt Klinik Für Dermatologie, Venerologie Und Allergologie, Frankfurt am main, Hessen, 60590, Germany|Fachklinik Bad Bentheim - Dermatologische Studienambulanz, Bad Bentheim, Niedersachsen, 48455, Germany|Dermatologische Studienambulanz, Bochum, Nordrhein-Westfalen, 44791, Germany|University Hospital Muenster, Münster, Nordrhein-westfalen, 48149, Germany|Clinical Research Center for Hair and Skin Science, Dept of Dermatology, Charité Universitätsmedizin Berlin, Berlin, 10117, Germany|Universitätsklinikum Erlangen Hautklinik, Erlangen, 91054, Germany|Pécsi Tudományegyetem Klinikai Központ, Bőr-, Nemikórtani És Onkodermatológiai Klinika, Pécs, Baranya, 7632, Hungary|Szte Áok Szent-Györgyi Albert Klinikai Központ Bőrgyógyászati És Allergológiai Klinika, Szeged, Csongrád-csanád, 6720, Hungary|Bugát Pál Kórház, Gyöngyös, Heves, 3200, Hungary|Semmelweis Egyetem, Általános Orvostudományi Kar, Bőr-, Nemikórtani És Bőronkológiai Klinika, Budapest, Pest, 1085, Hungary|Wromedica I. Bielicka, A. Strzalkowska S.C., Wrocław, Dolnośląskie, 50-685, Poland|Twoja Przychodnia - Centrum Medyczne Nowa Sól, Nowa Sól, Lubuskie, 67-100, Poland|Etg Siedlce, Siedlce, Mazowieckie, 08-110, Poland|Ot.Co Clinic Klinika Osipowicz & Turkowski Sp. Z O.O., Warszawa, Mazowieckie, 00-716, Poland|Rcmed Oddzial Warszawa, Warszawa, Mazowieckie, 00-892, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, Mazowieckie, 02-664, Poland|Etg Warszawa, Warszawa, Mazowieckie, 02-793, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Etg Skierniewice, Skierniewice, Łódzkie, 96-100, Poland|Hospital Del Mar, Barcelona, Cataluña, 08001, Spain|Hospital Santa Creu I Sant Pau, Barcelona, Cataluña, 08041, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario Reina Sofia, Córdoba, 14004, Spain|Hospital Universitario Ramón Y Cajal - Edificio Consultas Externas, Madrid, 28034, Spain|Hospital Doce de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Infanta Leonor, Madrid, 28081, Spain"
NCT04228029,Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids,https://clinicaltrials.gov/study/NCT04228029,NO,Alopecia Areata,DEVICE: Carboxytherapy|DRUG: Intralesional Steroid Injection,ALL,ADULT,PHASE4,"Kasr ElAiny Hospital, Cairo university, Cairo, El Manial, 11956, Egypt"
NCT05502952,Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study,https://clinicaltrials.gov/study/NCT05502952,NO,Alopecia Areata,DRUG: Pentoxifylline,ALL,"ADULT, OLDER_ADULT",NA,"Sohag University Hospital, Sohag, Egypt"
NCT01950780,Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata,https://clinicaltrials.gov/study/NCT01950780,YES,Alopecia Areata,DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States"
NCT04147845,Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04147845,NO,Alopecia Areata,OTHER: Fractional Carbon Dioxide Laser|OTHER: Microneedling using dermapen|OTHER: Triamcinolone Acetonide|OTHER: Platelet-rich plasma,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Faculty of Medicine, Alexandria University, Alexandria, Egypt"
NCT03535233,Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03535233,NO,Alopecia Areata,DRUG: Triamcinolone Acetonide|DRUG: Minoxidil 5 % Topical Spray|DRUG: clobetasol propionate,ALL,"ADULT, OLDER_ADULT",PHASE4,
NCT01520077,Vytorin in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01520077,NO,Alopecia Areata,DRUG: vytorin,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of Miami, Miami, Florida, 33136, United States"
NCT03651752,DPCP for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03651752,NO,Alopecia Areata,DRUG: Diphenylcyclopropenone (DPCP) Ointment,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States"
NCT01328678,A Study of Vitamin D in Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT01328678,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Avera Research Institute, Sioux Falls, South Dakota, 57105, United States"
NCT04299503,Topical Crisaborole in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04299503,NO,Alopecia Areata,DRUG: Crisaborole Topical Ointment|DRUG: Placebo Topical Ointment,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, 02111, United States"
NCT02684123,Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684123,YES,Alopecia Areata,DRUG: Apremilast|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",NA,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT02299297,"Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis",https://clinicaltrials.gov/study/NCT02299297,YES,Alopecia Areata,DRUG: Tofacitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, New York, New York, 10032, United States"
NCT05599607,Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05599607,NO,Alopecia Areata,DIETARY_SUPPLEMENT: Probiotic mixture|DIETARY_SUPPLEMENT: Placebo,ALL,"ADULT, OLDER_ADULT",NA,"Centro Dermatológico Estético, Alicante, 03014, Spain"
NCT04338295,Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04338295,NO,Alopecia Areata,DEVICE: Tattoo machine (SOL Nova Device),MALE,"ADULT, OLDER_ADULT",NA,"Yale University, New Haven, Connecticut, 06519, United States"
NCT03359356,Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT03359356,YES,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|The Rockefeller University Laboratory for Investigative Dermatology, New York, New York, 10065-6399, United States"
NCT04518995,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1),https://clinicaltrials.gov/study/NCT04518995,YES,Alopecia Areata,DRUG: CTP-543 matching placebo|DRUG: CTP-543|DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35205, United States|Kern Research, Inc., Bakersfield, California, 93301, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|UC Irvine Dermatology Clinical Research Center, Irvine, California, 92697, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente, Oakland, California, 94611, United States|Kaiser Permanente South Sacramento, Sacramento, California, 95823, United States|Kaiser Permanente, San Francisco, California, 94118, United States|Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Denver, Colorado, 80210, United States|Yale University, Church Street Research Unit, New Haven, Connecticut, 06519, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, 33172, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, 33607, United States|Forward Clinical Trials Inc., Tampa, Florida, 33624, United States|Denova Research, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Department of Dermatology, Chicago, Illinois, 60611, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DS Research, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Qualmedica Research LLC, Owensboro, Kentucky, 42301, United States|Massachusetts General Hospital - Clinic, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|Skin Laser and Surgery Specialists of NJ, Hackensack, New Jersey, 07601, United States|Sadick Research Group, New York, New York, 10075, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem, North Carolina, 27157, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Dermatology Associates Of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|PEAK Research, Upper Saint Clair, Pennsylvania, 15241, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Palmetto Clinical Trial Services, Fountain Inn, South Carolina, 29644, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Austin Institute for Clinical Research, Inc., Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States|Clinical Investigation Specialists, Inc., Kenosha, Wisconsin, 53144, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Kirk Barber Research, Calgary, Alberta, T2G 1B1, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|Dr Wei Jing Loo Medicine Professional Corporation, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|Dr. S. K. Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|JRB Research Inc., Ottawa, Ontario, K1H 7X3, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|K. Papp Clinical Research Inc., Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc. - Clinic, Montreal, Quebec, H2X 2V1, Canada|Hôpital Saint-André - Chu de Bordeaux, Bordeaux, Nouvelle-aquitaine, 33075, France|Hôpital Saint-Louis - Gh de La Rochelle, La Rochelle, Nouvelle-aquitaine, 17000, France|Hôpital Hotel Dieu - Chu de Nantes, Nantes, PAYS DE LA Loire, 44093, France|Hôpital La Timone-Dermatologie, Marseille, 13385, France|Hôpital Saint Louis, Centre de Santé Sabouraud, Paris, 75010, France|Vita Longa Sp.Zo.O, Katowice, 40-748, Poland|SGD S.C., Krakow, 31-147, Poland|My Clinic, Warsaw, 00-144, Poland|Royalderm Agnieszka Nawrocka, Warsaw, 02-962, Poland|Hospital Clínico Y Provincial de Barcelona, Barcelona, 8036, Spain|H. U. Ramón y Cajal, Madrid, 28034, Spain"
NCT01673789,Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT01673789,NO,Alopecia Areata,DEVICE: Stem Cell Educator,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, China"
NCT05556265,A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT05556265,NO,Alopecia Areata,DRUG: Deucravacitinib|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Local Institution - 0016, Santa Monica, California, 90404-2120, United States|Local Institution - 0036, New Haven, Connecticut, 06510, United States|Local Institution - 0018, Tampa, Florida, 33624-2038, United States|Local Institution - 0023, Clinton Township, Michigan, 48038-1137, United States|Local Institution - 0024, New York, New York, 10029-6501, United States|Local Institution - 0019, Chapel Hill, North Carolina, 27516-4061, United States|Local Institution - 0011, Portland, Oregon, 97201-5134, United States|Local Institution - 0032, Pittsburgh, Pennsylvania, 15213-3403, United States|Local Institution - 0012, Austin, Texas, 78759, United States|Local Institution - 0013, Houston, Texas, 77004-8098, United States|Local Institution - 0014, San Antonio, Texas, 78213-2250, United States|Local Institution - 0017, South Jordan, Utah, 84095, United States|Local Institution - 0003, Kogarah, New South Wales, 2217, Australia|Local Institution - 0005, Carlton, Victoria, 3053, Australia|Local Institution - 0015, Winnipeg, Manitoba, R3M 3Z4, Canada|Local Institution - 0021, Markham, Ontario, L3P 1X2, Canada|Local Institution - 0009, Peterborough, Ontario, K9J 5K2, Canada|Local Institution - 0010, Richmond Hill, Ontario, L4C 9M7, Canada|Local Institution - 0034, Montreal, Quebec, H2X 2V1, Canada|Local Institution - 0027, Québec, Quebec, G1V 4X7, Canada|Local Institution - 0033, Nice, 06200, France|Local Institution - 0020, Paris, 75010, France|Local Institution - 0031, Hamamatsu-Shi, 431-3192, Japan|Local Institution - 0028, Koto-Ku, 136-0075, Japan|Local Institution - 0030, Mitaka-Shi, 181-8611, Japan|Local Institution - 0029, Shinjuku-Ku, 160-0023, Japan|Local Institution - 0026, Wroclaw, DS, 50-566, Poland|Local Institution - 0025, Warsaw, 02-962, Poland"
NCT05470413,Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05470413,NO,Alopecia Areata,DRUG: SHR0302|DRUG: SHR0302|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China|China-Japan Friendship Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|Zhujiang Hospital of Southern Medical University, Guanzhou, Guangdong, China|Shenzhen People's Hospital, Shenzhen, Guangdong, China|Henan Provincial People's Hospital, Zhengzhou, Henan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|The second xiangya hospital of central south university, Changsha, Hunan, China|Xiangya Hospital Of Central South University, Changsha, Hunan, China|Dermatology Hospital of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China|Jiangsu Province People's Hospital, Nanjing, Jiangsu, China|Wuxi No.2 People's Hospital, Wuxi, Jiangsu, China|Jiangxi Provincial Hospital of Dermatology, Nanchang, Jiangxi, China|The First Hospital of Jilin University, Changchun, Jilin, China|Shengjing Hospital Of China Medical University, Shengyang, Liaoning, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, China|First Hospital Of Shanxi Medical University, Taiyuan, Shanxi, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China|West China Hospital Sichuan University, Chengdu, Sichuan, China|Hangzhou First People's Hospital, Hangzhou, Zhejiang, China|Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China|The First Affiliated Hospital Of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"
NCT01898806,Intralesional Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01898806,YES,Alopecia Areata,DRUG: Intralesional Triamcinolone 2.5 mg/ml|DRUG: Intralesional Triamcinolone 5 mg/ml|DRUG: Intralesional Triamcinolone 10 mg/ml|DRUG: Intralesional Saline,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States"
NCT01917058,A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT01917058,NO,Alopecia Areata,DRUG: Abatacept|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, Dept of Dermatology, New York, New York, 10032, United States"
NCT04740970,A Study of JNJ-64304500 in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT04740970,NO,Alopecia Areata,DRUG: JNJ-64304500|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Forcare Clinical Research, Inc., Tampa, Florida, 33613, United States|Indiana Clinical Trial Center, Plainfield, Indiana, 46168, United States|Dermatology Specialists, Louisville, Kentucky, 40241, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|University of Pittsburgh Department of Dermatology, Pittsburgh, Pennsylvania, 15213, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Center for Clinical Studies, Webster, Texas, 77598, United States|Sinclair Dermatology, East Melbourne, 3002, Australia|Fremantle Dermatology, Fremantle, 6160, Australia|St George Dermatology & Skin Cancer Centre, Kogarah, 2217, Australia|Veracity Clinical Research, Woolloongabba, 4102, Australia|CHU Bordeaux - Hopital St Andre, Bordeaux, 33000, France|CHU de Nice Hopital de l Archet, Nice, 06200, France|CHU Rouen - Hopital Charles Nicolle, Rouen, 76031, France|Hamamatsu University Hospital, Hamamatsu, 431-3192, Japan|Kyorin University Hospital, Mitaka, 181-8611, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|The Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, 136-0075, Japan|Tokyo Medical University Hospital, Tokyo, 160-0023, Japan|Yamaguchi University Hospital, Ube, 755-8505, Japan"
NCT05255237,Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05255237,NO,Alopecia Areata,DRUG: Jaktinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"11 Xizhimen South Street, Beijing, Beijing, China"
NCT06340360,A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA),https://clinicaltrials.gov/study/NCT06340360,NO,Alopecia Areata,DRUG: Rezpegaldesleukin|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Quest Dermatology Research, Northridge, California, 91324, United States|Atlanta Biomedical Clinical Research, Atlanta, Georgia, 30331, United States|Clinical Investigation Specialists, Inc., Gurnee, Illinois, 60031, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|ALLCUTIS Research, LLC., Portsmouth, New Hampshire, 03801, United States|Sadick Research Group LLC, New York, New York, 10075, United States|DermDox Centers for Dermatology, Camp Hill, Pennsylvania, 17011, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 786660, United States|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Centre de Recherche Saint-Louis SHERBROOKE, Sherbrooke, Quebec, J1G 1X9, Canada"
NCT02553330,A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA),https://clinicaltrials.gov/study/NCT02553330,YES,Alopecia Areata,DRUG: Placebo Cream|DRUG: Ruxolitinib Phosphate Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Birmingham, Alabama, United States|Hot Springs, Arkansas, United States|New Haven, Connecticut, United States|Trumbull, Connecticut, United States|Miami, Florida, United States|Beverly, Massachusetts, United States|Boston, Massachusetts, United States|Clinton Township, Michigan, United States|Fort Gratiot, Michigan, United States|Fridley, Minnesota, United States|Minneapolis, Minnesota, United States|Winston-Salem, North Carolina, United States|Cleveland, Ohio, United States|Portland, Oregon, United States|Austin, Texas, United States|Houston, Texas, United States|Katy, Texas, United States|Norfolk, Virginia, United States"
NCT02350023,Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT02350023,NO,Alopecia Areata,DRUG: Topical latanoprost 0.005%|DRUG: Topical betamethasone 0.05%,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Dept of Dermatology, PGIMER, Chandigarh, 160012, India"
NCT04346316,A Phase II Study in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04346316,NO,Alopecia Areata,DRUG: SHR0302,ALL,"ADULT, OLDER_ADULT",PHASE2,"Quest Dermatology Research, Northridge, California, 91324, United States|Moore Clinical Research, Brandon, Florida, 33511, United States|Dawes Fretzin Clinical Research, Indianapolis, Indiana, 46250, United States|Skin Search of Rochester, Inc, Rochester, New York, 14623, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|The Skin Wellness Center, Knoxville, Tennessee, 37922, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|Novatrials, Kogarah, New South Wales, 2289, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Sinclair Dermatology, Melbourne, Victoria, 3002, Australia|China-Japan Friendship Hospital, Beijing, Beijing, 100029, China|Peking University First Hospital, Beijing, Beijing, 100034, China|Peking University People's Hospital, Beijing, Beijing, 100044, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, 100730, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Chongqing Traditional Chinese medicine Hospital, Chongqing, Chongqing, 400011, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, 400016, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510030, China|The Dermatology Hospital of Nanfang Medical University, Guangzhou, Guangdong, China|The Dermatology Hospital of Nanfang Medical University, Guangzhou, Guangzhou, China|Henan Provincial People's Hospital, Zhengzhou, Henan, 450003, China|Jiangsu Province People's Hospital, Nanjin, Jiangsu, 210029, China|The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, 200071, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300120, China|The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China|SIR RUN RUN Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China"
NCT06444451,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06444451,NO,Alopecia Areata,DRUG: Amlitelimab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Vital Prospects Clinical Research Institute, P.C. Site Number : 8400004, Tulsa, Oklahoma, 74136, United States|Health Concepts Site Number : 8400001, Rapid City, South Dakota, 57702, United States|Investigational Site Number : 0360003, East Melbourne, Victoria, 3002, Australia|Investigational Site Number : 1240001, Winnipeg, Manitoba, R3M 3Z4, Canada|Investigational Site Number : 1240006, Markham, Ontario, L3P 1X3, Canada"
NCT06060977,"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants",https://clinicaltrials.gov/study/NCT06060977,NO,Alopecia Areata (AA),DRUG: IMG-007,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A., Rogers, Arkansas, 72758, United States|Torrance Clinical Research Institute Inc., Lomita, California, 90717, United States|Alliance Clinical Research of Tampa, Tampa, Florida, 33615, United States|Dawes Fretzin Clinical Resarch Group, LLC, Indianapolis, Indiana, 47906, United States|Options Research Group, West Lafayette, Indiana, 47906, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, 01803, United States|Great Lakes Research Group Inc., Bay City, Michigan, 48706, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Skin Search of Rochester, Inc., Rochester, New York, 14623, United States|Stride Clinical Research LLC, Sugar Land, Texas, 77479, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|SimcoMed Health Ltd., Barrie, Ontario, L4M7G1, Canada|Skin Health, Cobourg, Ontario, K9A0Z4, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L0B7, Canada|Research Toronto, Toronto, Ontario, M2W2N4, Canada|Centre de Recherche Saint-Louis, Québec, Quebec, G1W4R4, Canada|Innovaderm Research Inc., Montréal, Canada"
NCT05051761,Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05051761,NO,Alopecia Areata,DRUG: Jaktinib|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Peking University People's Hospital, Beijing, Beijing, 100044, China|Hospital for Skin Diseases, Chinese Academy of medical Sciences, Nanjing, Jiangsu, 210042, China"
NCT05041803,European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05041803,NO,Alopecia Areata,DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Service de Dermatologie CHRU de Brest - Hopital Morvan, Brest Cedex, Finistere, 29609, France|Service de Dermatologie Centre Hospitalier Universitaire de Nice - Hopital Archet 2, Nice, Provence-Alpes-Cote d'Azur, 06202, France|CHU de Bordeaux, Hopital Saint-Andre, Bordeaux, 33000, France|Hopital Saint-Louis - GH De La Rochelle-Re-Aunis, La Rochelle, 17019, France|Hôpital La Timone-Dermatologie, Marseille, 13385, France|Hopital de l'Hotel Dieu - CHU de Nantes, Nantes, 22093, France|Hôpital Saint Louis, Centre de Santé Sabouraud, Paris, 75010, France|Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse, 31059, France|Universitätsklinikum Tübingen Universitäts-Hautklinik, Tübingen, Baden-Wüttermberg, 72076, Germany|Universitätsklinikum Erlangen, Hautklinik, Erlangen, Bayern, 91054, Germany|Klinikum Rechts der Isar, Technische Universität München, Hautklinik, München, Bayern, 80802, Germany|Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt am Main, Hessen, 60590, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Klinik für Dermatologie und Venerologie, Zentrale Studienkoordination für innovative Dermatologie (ZiD), Münster, Nordrhein-Westfalen, 48149, Germany|Clinical Research Center for Hair and Skin Science, Dept of Dermatology, Charité Universitätsmedizin Berlin, Berlin, 10117, Germany|Pecsi Tudomanyegyetem Klinikai Kozpont, Bor-, Nemikortani es Onkodermatologiai Klinika, Pécs, Baranya County, 7632, Hungary|SZTE AOK Szent-Gyorgyi Albert Klinikai Kozpont, Borgyogyaszati es Allergologiai Klinika, Szeged, Csongrad-Csanad County, 6720, Hungary|Semmelweis Egyetem AOK, Bor-, Nemikortani es Boronkologiai Klinika, Budapest, Pest, 1085, Hungary|Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa Sól, Lubuskie, 67-100, Poland|ETG Siedlce, Siedlce, Mazowieckie, 08-110, Poland|ETG Skierniewice, Skierniewice, Mazowieckie, 96-100, Poland|RCMed Oddzial w Sochaczewie, Sochaczew, Mazowieckie, 96-500, Poland|ETG Warszawa, Warsaw, Mazowieckie, 02-793, Poland|OT.CO Clinic Klinika Osipowicz & Turkowski sp. z o.o, Warszawa, Mazowieckie, 00-716, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, Mazowieckie, 02-661, Poland|NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL, Białystok, 15-453, Poland|Vita Longa Sp.Zo.O, Katowice, 40-748, Poland|Specjalistyczny Gabinet Dermatologiczny s.c., Kraków, 30-002, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-500, Poland|My Clinic, Warsaw, 00-144, Poland|Royalderm Agnieszka Nawrocka, Warsaw, 02-962, Poland|WroMedica I. Bielicka, A. Strazalkowska s.c., Wroclaw, 51-685, Poland|Hospital Clínic de Barcelona, Barcelona, Barcelona/Cataluña, 08036, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital de La Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Reina Sofía, Córdoba, 14004, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain"
NCT05205070,A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05205070,NO,Alopecia Areata,BIOLOGICAL: Rosnilimab|BIOLOGICAL: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"10-105, Birmingham, Alabama, 35205, United States|Site10-103, Encinitas, California, 92024, United States|Site 10-113, Northridge, California, 91324, United States|Site 10-115, Chicago, Illinois, 60611, United States|10-104, Indianapolis, Indiana, 46250, United States|Site 10-109, Plainfield, Indiana, 46168, United States|Site 10-116, Louisville, Kentucky, 40241, United States|Site 10-117, Clarkston, Michigan, 48346, United States|Site 10-111, New York, New York, 10029, United States|Site 10-101, Charlotte, North Carolina, 28277, United States|Site 10-102, Bexley, Ohio, 43208, United States|Site 10-106, Tulsa, Oklahoma, 74136, United States|10-107, Upper Saint Clair, Pennsylvania, 15241, United States|10-110, Houston, Texas, 77056, United States|Site 10-108, San Antonio, Texas, 78229, United States|Site 10-114, Kenosha, Wisconsin, 53144, United States"
NCT04784533,A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04784533,NO,Alopecia Areata,DRUG: CTP-543|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Kern Research, Inc., Bakersfield, California, 93301, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|University of California, Irvine, Irvine, California, 92697, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente, Oakland, California, 94611, United States|Palmtree Clinical Research, Inc., Palm Springs, California, 92262, United States|Kaiser Permanente, San Francisco, California, 94118, United States|Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Inc., Denver, Colorado, 80210, United States|Yale University Church Street Research Unit, New Haven, Connecticut, 06519, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|DeNova Research, Chicago, Illinois, 60611, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Michigan Center for Research Company, LLC, Clarkston, Michigan, 48346, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|Minnesota Clinical Study Center, New Brighton, Minnesota, 55112, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|Skin Laser and Surgery Specialists of New Jersey, Hackensack, New Jersey, 07601, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|North Carolina Dermatology Associates, PLLC, Raleigh, North Carolina, 27617, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Remington Davis, Columbus, Ohio, 43215, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Northwest Dermatology, Portland, Oregon, 97210, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|PEAK Research, LLC, Upper Saint Clair, Pennsylvania, 15241, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Dermatology Treatment and Research Center, PA, Dallas, Texas, 75230, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Springville Dermatology/CCT Research, Springville, Utah, 84663, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States"
NCT04003376,Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata,https://clinicaltrials.gov/study/NCT04003376,NO,Alopecia Areata,DEVICE: fractional carbon dioxide laser alone|DRUG: Triamcinolone Acetonide 10mg/mL|BIOLOGICAL: platelet rich plasma|DRUG: vitamin D solution,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Assiut University Hospital, Assiut, Egypt"
NCT02018042,An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata,https://clinicaltrials.gov/study/NCT02018042,YES,Alopecia Areata,DRUG: Abatacept,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center - Department of Dermatology, New York, New York, 10032, United States"
NCT04034134,Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04034134,NO,Alopecia Areata,DRUG: Jaktinib Hydrochloride Tablets|DRUG: Jaktinib Hydrochloride Tablets|DRUG: Jaktinib Hydrochloride Tablets,ALL,"ADULT, OLDER_ADULT",PHASE2,"Chongqing Chinese Traditional Medicine Hospital, Chongqing, Chongqing, 400011, China|The second xaingya hospital of central south university, Changsha, Hunan, 410011, China"
NCT01453686,A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata,https://clinicaltrials.gov/study/NCT01453686,NO,Alopecia Areata,DRUG: Hydrocortisone 1%|DRUG: Clobetasol Propionate 0.05%,ALL,CHILD,PHASE3,"The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada"
NCT05650333,A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age,https://clinicaltrials.gov/study/NCT05650333,NO,Alopecia Areata,DRUG: Ritlecitinib 20 mg,ALL,CHILD,PHASE1,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Pediatric Skin Research,LLC, Coral Gables, Florida, 33146, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87102, United States|UNMH, Albuquerque, New Mexico, 87106, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States"
NCT02684097,A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684097,YES,Alopecia Areata,DRUG: Tralokinumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT06157905,Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06157905,NO,Extensive Alopecia Areata,DRUG: Oral Tofacitinib citrate,ALL,ADULT,EARLY_PHASE1,"Services Institute of Medical Sciences, Lahore, Punjab, 54000, Pakistan"
NCT03898479,Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03898479,NO,Alopecia Areata,DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35203, United States|Alliance Dermatology & MOHS Center, Phoenix, Arizona, 85032, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Northwest Arkansas Clinical Trials Center, PLLC, Rogers, Arkansas, 72758, United States|Kern Research Inc., Bakersfield, California, 93301, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|University of California, Irvine, Irvine, California, 92697, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente Northern California - Oakland, Oakland, California, 94611, United States|Palmtree Clinical Research, Inc., Palm Springs, California, 92262, United States|Stanford University School of Medicine - Medical Dermatology Clinic, Redwood City, California, 94063, United States|Kaiser Permanente South Sacramento, Sacramento, California, 95823, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Colorado Center for Dermatology, PLLC d/b/a CODerm Research, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Denver, Colorado, 80210, United States|Yale University Church Street Research Unit, New Haven, Connecticut, 06519, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|University of Miami Hospital, Miami, Florida, 33125, United States|Floridian Research Institute, LLC, Miami, Florida, 33179, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, 33172, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, 33607, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|ASR, LLC, Boise, Idaho, 83702, United States|Denova Research, Chicago, Illinois, 60611, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DS Research, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Qualmedica Research, Owensboro, Kentucky, 42301, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|Clinical Research Institute of Michigan, Clinton Township, Michigan, 48038, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55417, United States|Vivida Dermatology, Las Vegas, Nevada, 89119, United States|Skin Laser and Surgery Specialists of NJ, Hackensack, New Jersey, 07601, United States|Schweiger Dermatology, P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Sadick Research Group, New York, New York, 10075, United States|UR Dermatology at College Town, Rochester, New York, 14620, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|North Carolina Dermatology Associates, PLLC, Raleigh, North Carolina, 27617, United States|Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem, North Carolina, 27104, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Remington-Davis, Inc., Columbus, Ohio, 43215, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|NW Dermatology Institute, Portland, Oregon, 97210, United States|Hospital of the University of Pennsylvania Dept of Dermatology, Philadelphia, Pennsylvania, 19104, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Peak Research - Pennsylvania, Upper Saint Clair, Pennsylvania, 15241, United States|Velocity Clinical Research-Providence, East Greenwich, Rhode Island, 02818, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Palmetto Clinical Trial Services, Fountain Inn, South Carolina, 29644, United States|Dermatology Treatment and Research Center - Dallas, Dallas, Texas, 75230, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Suzanne Bruce and Associates, PA, Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Jordan Valley Dermatology, West Jordan, Utah, 84088, United States|University of Virginia Health System, Charlottesville, Virginia, 22903, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States|Clinical Investigation Specialists, Inc., Kenosha, Wisconsin, 53144, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Kirk Barber Research, Calgary, Alberta, T2G 1B1, Canada|Care Clinic, Red Deer, Alberta, T4P 1K4, Canada|Medical Arts Health Research Group, Kelowna, British Columbia, V1Y 4N7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|Dr. S. K. Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|JRB research Inc., Ottawa, Ontario, K1H 7X3, Canada|Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec, G1V 4X7, Canada"
NCT02561585,LEO 124249 Ointment in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02561585,YES,Alopecia Areata,DRUG: LEO 124249|OTHER: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"Northwestern University, Evanston, Illinois, 60208, United States|The Icahn School of Medicine, Mount Sinai Hospital, New York, New York, 10029, United States"
NCT03941548,Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03941548,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 Matching Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|Dr Wei Jing Loo Medicine Professional Corporation, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada"
NCT00999869,The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata,https://clinicaltrials.gov/study/NCT00999869,NO,Alopecia Areata,DRUG: Botulinum toxin type A|DRUG: Triamcinolone acetonide,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand|Siriraj hospital, Bangkok, 10700, Thailand"
NCT02557074,TREg Activation in the Treatment of the PELADE (Alopecia Areata),https://clinicaltrials.gov/study/NCT02557074,NO,Alopecia Areata,DRUG: IL2|DRUG: placebo,ALL,ADULT,PHASE3,"AP-HM - La timone - Dermatologie, Marseille, Bouche Du Rhône, 13005, France|AP-HP St Louis - Dermatologie, Paris, Ile De France, 75000, France|CHU de Nimes - Dermatologie, Nîmes, Languedoc-Roussillon, 30000, France|CHI St Raphael Fréjus - Dermatologie, Fréjus, Paca, 83000, France|CHU Montpellier - Dermatologie, Montpellier, 34000, France|CHU de Nice - dermatologie, Nice, 06200, France"
NCT03899259,A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03899259,YES,Alopecia Areata,DRUG: Baricitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Investigate MD, Scottsdale, Arizona, 85255, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente Hospital, San Francisco, California, 94118, United States|New England Research Associates, Bridgeport, Connecticut, 06606, United States|Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, 33134, United States|New Horizon Research Center, Miami, Florida, 33165, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The South Bend Clinic Center for Research, South Bend, Indiana, 46617, United States|Qualmedica Research, LLC, Owensboro, Kentucky, 42303, United States|Dermatology and Skin Cancer Specialists, Rockville, Maryland, 20850, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, 48047, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Associated Skin Care Specialists, New Brighton, Minnesota, 55112, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Joseph J. Schwartz, M.D., Troy, New York, 12180, United States|University of North Carolina Dermatology and Skin Cancer Cen, Chapel Hill, North Carolina, 27516, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|M3-Emerging Medical Research, Raleigh, North Carolina, 27612, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Velocity Clinical Research, Providence, East Greenwich, Rhode Island, 02818, United States|Center for Medical Research, LLC, Providence, Rhode Island, 02908, United States|Suzanne Bruce and Associates, PA, Houston, Texas, 77056, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Stat Research, Caba, Buenos Aires, C1013AAB, Argentina|Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aires, Buenos Aires, C1027AAP, Argentina|Buenos Aires Skin, Buenos Aires, Ciudad Autónoma De Buenos Aires, 1055, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucuman, T4000AXL, Argentina|Fundacion Respirar, Buenos Aires, C1426ABO, Argentina|Instituto de Neumonología y Dermatología, Ciudad Autonoma Buenos Aires, 1425, Argentina|Parra Dermatología, Mendoza, 5500, Argentina|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|Skin & Cancer Foundation Australia, Westmead, New South Wales, 2045, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Clinical Trials SA Pty Ltd, Adelaide, South Australia, 5073, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Fremantle Dermatology, Perth, Western Australia, 6160, Australia|Sinclair Dermatology, Victoria, 3002, Australia|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90020-090, Brazil|IDERJ - Instituto de Dermatologia e Estética do Brasil, Rio de Janeiro, RJ, 22470-220, Brazil|Faculdade de Ciências Médicas - UNICAMP, Campinas, Sao Paulo, 13083-887, Brazil|Fundação Faculdade de Medicina do ABC, Santo André, Sao Paulo, 09060-870, Brazil|Centro de Pesquisa Sao Lucas, Campinas, São Paulo, 13034-685, Brazil|IBPClin - Instituto Brasil de Pesquisa Clínica, Rio de Janeiro, 22241-180, Brazil|Hospital Central - Santa Casa de São Paulo, São Paulo, 01223-001, Brazil|Hospital de Servidor Publico Estadual, São Paulo, 04039-901, Brazil|Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, 100020, China|Beijing Friendship Hospital Affiliate of Capital University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|Guangdong Province Dermatology Hospital, Guangzhou, Guangdong, 510018, China|Xiangya Hospital Central South University, Changsha, Hunan, 410008, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, Shaanxi, 710004, China|1st affiliated Hospital of Shanxi Medical University, Tai Yuan, Shan XI, 030001, China|HuaShan Hospital Affiliated To Fudan University, Shanghai, Shanghai, 200040, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310052, China|Chinese PLA General Hospital, Beijing, 100853, China|Shanghai Dermatology Hospital, Shanghai, 200071, China|Tianjin Medical University General Hospital, Tianjin, 300052, China|Emek Medical Center, Afula, 1834111, Israel|Soroka Medical Center, Beer Sheva, 8410101, Israel|Rambam Medical Center, Haifa, 3109601, Israel|Hadassah Medical Center, Jerusalem, 9112001, Israel|Rabin Medical Center, Petach Tikva, 4941492, Israel|Sheba Medical Center, Ramat Gan, 5262100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|Yokohama Rosai Hospital, Yokohama, Kanagawa, 222-0036, Japan|Hamamatsu University School of Medicine, University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, 113-8431, Japan|Kyorin University Hospital, Mitaka, Tokyo, 181-8611, Japan|Tokyo Medical Univ. Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, 136-0075, Japan|Dankook University Hospital, Cheonan, Chungcheongnam-do, 31116, Korea, Republic of|Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi-do, 14584, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, 16499, Korea, Republic of|Boramae Medical Center, Dongjak-gu, Seoul-teukbyeolsi [Seoul], 07061, Korea, Republic of|Kyunghee University Hospital at Gangdong, Seoul, Seoul-teukbyeolsi [Seoul], 134-090, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Clinical Research Puerto Rico, San Juan, 00909, Puerto Rico|Chung Shan Medical University Hospital, Taichung City (r.o.c), 402, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei City, 10002, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan, 333, Taiwan"
NCT03811912,Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03811912,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 Matching Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigative Site, Irvine, California, 92697, United States|Investigative Site, San Francisco, California, 94118, United States|Investigative Site, New Haven, Connecticut, 06519, United States|Investigative Site, Boynton Beach, Florida, 33472, United States|Investigative Site, Boston, Massachusetts, 02114, United States|Investigative Site, Boston, Massachusetts, 02115, United States|Investigative Site, Fridley, Minnesota, 55432, United States|Investigative Site, Portsmouth, New Hampshire, 03801, United States|Investigative Site, Winston-Salem, North Carolina, 27104, United States|Investigative Site, Portland, Oregon, 97210, United States"
NCT01246284,The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01246284,NO,Alopecia Areata,DRUG: Triamcinolone acetonide|OTHER: Normal saline,ALL,"ADULT, OLDER_ADULT",NA,"The Skin Care Center, Vancouver General Hospital, 835 West 10th Ave, Vancouver, British Columbia, Canada"
NCT02974868,Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT02974868,YES,Alopecia Areata,DRUG: PF-06651600|DRUG: PF-06700841|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Alabama at Birmingham, Dermatology at the Whitaker Clinic, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, The Kirklin Clinic, Birmingham, Alabama, 35233, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Office of F. Monte Purcelli, Santa Monica, California, 90404, United States|Tower Saint John's Imaging, Santa Monica, California, 90404, United States|University of Colorado Hospital Clinical and Translational Research Center, Inpatient Unit, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Outpatient Clinic, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Investigational Drug Services, New Haven, Connecticut, 06511, United States|Church Street Research Unit, New Haven, Connecticut, 06519, United States|Yale Hearing and Balance Center, New Haven, Connecticut, 06519, United States|Yale New Haven Hospital, New Haven, Connecticut, 06519, United States|Park Avenue Dermatology Administrative Annex, Orange Park, Florida, 32073, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|Edward B. Kampsen, MD, Tampa, Florida, 33609, United States|Olympian Clinical Research, Tampa, Florida, 33609, United States|Rose Radiology, Tampa, Florida, 33609, United States|Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|MedaPhase Inc., Newnan, Georgia, 30263, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46256, United States|Dawes Fretzin Dermatology Group, LLC, Indianapolis, Indiana, 46256, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS), Boston, Massachusetts, 02114, United States|Weill Cornell Medicine, New York, New York, 10021, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Mount Sinai Department of Otolaryngology, New York, New York, 10029, United States|Rockefeller University Hospital, New York, New York, 10065, United States|Investigational Drug Service, Rochester, New York, 14642, United States|University of Rochester Audiology, Rochester, New York, 14642, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|University of Rochester Radiology, Rochester, New York, 14642, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|University of Utah MidValley Dermatology, Murray, Utah, 84107, United States|University of Utah Medical Center, Salt Lake City, Utah, 84132, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Hearing Life, Hurstville, New South Wales, 2220, Australia|Dr. Glen and Partners Medical Imaging, Kogarah, New South Wales, 2217, Australia|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|St. George Hearing and Balance Clinic, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Skin & Cancer Foundation Inc., Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Bridge Road Imag ing, Richmond, Victoria, 3121, Australia|Richmond Audiology, Richmond, Victoria, 3121, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|Research by ICLS, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|York Dermatology Center, Richmond Hill, Ontario, L4C 9M7, Canada"
NCT02604888,Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females,https://clinicaltrials.gov/study/NCT02604888,NO,Alopecia Areata,OTHER: MEXIS/M6S Patent - lotion against alopecia,ALL,"ADULT, OLDER_ADULT",NA,"George Mexis, Athens, 11253, Greece"
NCT01559584,Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01559584,NO,Alopecia Areata,RADIATION: ultraviolet A (UVA)|DRUG: Triamcinolone Acetonide,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Dermatology department - faculty of medicine- Cairo University, Cairo, Egypt"
NCT00408798,Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin,https://clinicaltrials.gov/study/NCT00408798,NO,Alopecia Areata,"DRUG: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units",ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, The Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT03325296,Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.,https://clinicaltrials.gov/study/NCT03325296,NO,Alopecia Areata,DRUG: LEO 124249|OTHER: Ointment vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigational site, Aarhus, 8000, Denmark|Investigational site, Gentofte, 2820, Denmark"
NCT00063076,Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata,https://clinicaltrials.gov/study/NCT00063076,NO,Alopecia Areata,DRUG: Targretin Gel 1%,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"UT MD Anderson Cancer Center, Houston, Texas, 77030, United States"
NCT03570749,A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03570749,NO,Alopecia Areata,DRUG: Baricitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|Coastal Clinical Research, Inc, Mobile, Alabama, 36608, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Tilda Research, Irvine, California, 92612, United States|University of California, Irvine, Irvine, California, 92697, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Stanford Medicine Outpatient Center, Redwood City, California, 94063, United States|University of California Davis Health, Sacramento, California, 95816, United States|University Clinical Trials, San Diego, California, 92123, United States|Mosaic Dermatology, Santa Monica, California, 90403, United States|Yale University School of Medicine, New Haven, Connecticut, 06519, United States|Solutions Through Advanced Research, Jacksonville, Florida, 32256, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Skin Care Physicians of Georgia, Macon, Georgia, 31217, United States|Medaphase Inc, Newnan, Georgia, 30263, United States|Northwestern University, Chicago, Illinois, 60611, United States|DS Research, Louisville, Kentucky, 40241, United States|Callender Center For Clinical Research, Glenn Dale, Maryland, 20769, United States|ActivMed Practices and Research, Beverly, Massachusetts, 01915, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis, Minnesota, 55455, United States|ActivMed Practices & Research, Inc., Portsmouth, New Hampshire, 03801, United States|Montefiore Medical Center, Bronx, New York, 10467-2490, United States|University of Rochester School of Medicine, Rochester, New York, 14642, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Ohio State University, Columbus, Ohio, 43230, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|The Pennsylvania Centre for Dermatology, LLC, Exton, Pennsylvania, 19341, United States|Penn State Univ. Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Penn Medicine: University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19104, United States|UPMC Clinical Trials, Pittsburgh, Pennsylvania, 15213, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Center for Clinical Studies, LTD.LLP, Webster, Texas, 77598, United States|University of Utah, Murray, Utah, 84107, United States|Dermatology Associates of Seattle, Seattle, Washington, 98101, United States|Kurume University Hospital, Kurume, Fukuoka, 830 0011, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Inha University Hospital, Incheon, Incheon-gwangyeoksi [Incheon], 22332, Korea, Republic of|Jeonbuk National University Hospital, Jeonju-si, Jeonrabugdo, 54907, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, 13620, Korea, Republic of|Pusan National University Hospital, Busan, Pusan-Kwangyǒkshi, 49241, Korea, Republic of|Chung-Ang University Hospital, Dongjak-gu, Seoul-teukbyeolsi [Seoul], 06973, Korea, Republic of|Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03080, Korea, Republic of|The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03312, Korea, Republic of|Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 05030, Korea, Republic of|Kyung-Hee University Hospital at Gangdong, Seoul, Seoul-teukbyeolsi [Seoul], 134-090, Korea, Republic of|Kyungpook National University Hospital, Jung-gu, Taegu-Kwangyǒkshi, 41944, Korea, Republic of|Chungnam National University Hospital, Daejeon, Taejǒn-Kwangyǒkshi, 35015, Korea, Republic of|RM Pharma Specialists, Mexico City, Distrito Federal, 3100, Mexico|Centro de Atención en Enfermedades Inflamatorias CATEI, Guadalajara, Jalisco, 44638, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S. C., Guadalajara, Jalisco, 44650, Mexico|Centro Regiomontano de Investigacion, Monterrey, Nuevo Leon, 64060, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, 64460, Mexico|B&B Investigaciones Medicas, SC, Mazatlan, Sinaloa, 82140, Mexico|Derma Norte del Bajío, Aguascalientes, 20130, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C, Durango, 34000, Mexico|Ponce Medical School Foundation Inc., Ponce, 00716, Puerto Rico|GCM Medical Group, PSC- Hato Rey Site, San Juan, 00917, Puerto Rico"
NCT06239324,Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser,https://clinicaltrials.gov/study/NCT06239324,NO,Alopecia Areata,DRUG: Latanoprost,ALL,ADULT,PHASE1|PHASE2,"Qena Hospital, Qinā, Egypt"
NCT02636244,Safety and Efficacy Study of SHAPE Gel in Alopecia Areata,https://clinicaltrials.gov/study/NCT02636244,NO,Alopecia Areata,DRUG: SHAPE Gel,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT03354637,A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03354637,YES,Alopecia Areata,DRUG: ATI-50002 high dose|DRUG: ATI-50002 low dose|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Encinitas, California, 92024, United States|Aclaris Investigator Site, Laguna Hills, California, 92653, United States|Aclaris Investigator Site, Redwood City, California, 94063, United States|Aclaris Investigator Site, Washington, District of Columbia, 20037, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Miami, Florida, 33136, United States|Aclaris Investigator Site, Boston, Massachusetts, 02115, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator Site, Warren, Michigan, 48088, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, New York, New York, 10155, United States|Aclaris Investigator Site, Durham, North Carolina, 27710, United States|Aclaris Investigator Site, Winston-Salem, North Carolina, 27104, United States|Aclaris Investigator Site, Portland, Oregon, 97210, United States|Aclaris Investigator Site, Fort Washington, Pennsylvania, 19034, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigator Site, Nashville, Tennessee, 37215, United States|Aclaris Investigator Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Austin, Texas, 78759, United States|Aclaris Investigator Site, San Antonio, Texas, 78229, United States|Aclaris Investigator Site, San Antonio, Texas, 78745, United States"
NCT03137381,Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03137381,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 matching placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California, Irvine, Irvine, California, 92697, United States|Contour Dermatology & Cosmetic Surgery Center, Rancho Mirage, California, 92270, United States|Stanford University School of Medicine, Redwood City, California, 94064, United States|Kaiser Permanente Northern California, San Francisco, California, 94118, United States|Yale School of Medicine, New Haven, Connecticut, 06519, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Northwestern University, Chicago, Illinois, 60611, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|Icahn School of Medicine at Mt. Sinai, New York, New York, 10029, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27104, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Northwest Dermatology, Portland, Oregon, 97210, United States|Suzanne Bruce & Associates, PA, Houston, Texas, 77056, United States"
NCT01797432,Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01797432,YES,Alopecia Areata,DRUG: Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10)|DEVICE: Restylane,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States"
NCT01017510,Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata,https://clinicaltrials.gov/study/NCT01017510,NO,Alopecia Areata,DEVICE: Subcutaneous injection luer syringe|DEVICE: DERMOJET (a syringe without a needle),ALL,"ADULT, OLDER_ADULT",NA,"Sheba Medical Center, Rmat Gan, Israel"
NCT00177021,Aldara for the Treatment of Extensive Alopecia Areata,https://clinicaltrials.gov/study/NCT00177021,NO,Alopecia Areata,DRUG: Aldara Cream 5%,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT00176969,Response of Topical Capsaicin in Alopecia Areata,https://clinicaltrials.gov/study/NCT00176969,NO,Alopecia Areata,DRUG: Capsaicin,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT00187577,Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00187577,NO,Alopecia Areata,DRUG: Latanoprost (Xalatan)|DRUG: Bimatoprost (Lumigan)|DRUG: Topical application of latanoprost solution to eyelid,ALL,"ADULT, OLDER_ADULT",NA,"University of California, San Francisco, San Francisco, California, 94117, United States"
NCT05551793,Regeneron AA Multicenter (Dupilumab),https://clinicaltrials.gov/study/NCT05551793,NO,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UR Dermatology at College Town, Rochester, New York, 14620, United States"
NCT03473600,Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation,https://clinicaltrials.gov/study/NCT03473600,NO,Alopecia Areata,PROCEDURE: Cryotherapy|DRUG: Triamcinolone acetonide injection,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Faculty of medicine, Assiut, 71111, Egypt"
NCT05954104,Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma,https://clinicaltrials.gov/study/NCT05954104,NO,Alopecia Areata,DRUG: Calcipotriol,ALL,"CHILD, ADULT",NA,"Faculty of Dentistary - Aswan University, Aswan, Egypt"
NCT06471114,Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA),https://clinicaltrials.gov/study/NCT06471114,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Chu Brest, Brest, 29609, France"
NCT05251831,Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP,https://clinicaltrials.gov/study/NCT05251831,NO,Alopecia Areata,DRUG: Intradermal injection,ALL,ADULT,EARLY_PHASE1,"Al-Azhar University in Cairo, Cairo, 11311, Egypt"
NCT01840046,Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01840046,NO,Alopecia Areata,DRUG: Interleukin-2,ALL,ADULT,PHASE1|PHASE2,"CHU de Nice - Hôpital Archet, Nice, Alpes-Maritimes, 06001, France"
NCT05522556,Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600),https://clinicaltrials.gov/study/NCT05522556,NO,Alopecia Areata,DRUG: Ritlecitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT00484679,Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00484679,YES,Alopecia Areata,DRUG: Triamcinolone Acetonide 10 mg/mL (Kenalog-10),ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT00176943,Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%,https://clinicaltrials.gov/study/NCT00176943,NO,Alopecia Areata,DRUG: Aldara Cream 5%,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT06279221,Litfulo Capsules Special Investigation,https://clinicaltrials.gov/study/NCT06279221,NO,Alopecia Areata,DRUG: LITFULO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Pfizer, Tokyo, Japan"
NCT06045624,A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects,https://clinicaltrials.gov/study/NCT06045624,NO,Alopecia Areata,DRUG: OR-101 (Single ascending dose)|DRUG: OR-101 (Food effect)|DRUG: OR-101 (Multiple ascending dose)|DRUG: Placebo,ALL,ADULT,PHASE1,"SCIENTIA Clinical Research Ltd, Randwick, New South Wales, 2031, Australia"
NCT04445363,A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT04445363,NO,Alopecia Areata(AA),DRUG: Jaktinib hydrochloride cream|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The Second Xaingya Hospital，central south university, Changsha, Hunan, 410011, China"
NCT05196711,A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects,https://clinicaltrials.gov/study/NCT05196711,NO,Alopecia Areata,DRUG: MAX-40070|DRUG: Placebo,ALL,ADULT,PHASE1,
NCT02037191,The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade,https://clinicaltrials.gov/study/NCT02037191,NO,ALOPECIA AREATA,DRUG: Methotrexate|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Head Dermatology Department, Rouen, Haute Normandie, 76031, France|CHU de Rouen - Hôpitaux de Rouen, Rouen, Seine Maritime, 76031, France"
NCT03078686,Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata,https://clinicaltrials.gov/study/NCT03078686,NO,Alopecia Areata|Scarring Alopecia,PROCEDURE: tSVF by lipoaspiration|PROCEDURE: PRP Concentration|PROCEDURE: Emulsification tSVF|PROCEDURE: cSVF isolation and concentration|PROCEDURE: cSVF in Normal Saline IV,ALL,"ADULT, OLDER_ADULT",NA,"Kenneth Williams, DO, Irvine, California, 92618, United States|Regeneris Medical, North Attleboro, Massachusetts, 02760, United States|Regenevita LLC, Stevensville, Montana, 59870, United States"
NCT06278402,"Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT06278402,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib,ALL,"CHILD, ADULT",PHASE3,"Misbah Zari Qadir, Karachi, Sindh, Pakistan"
NCT04238091,Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04238091,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Fecal material transfer therapy|PROCEDURE: 4mm Punch Biopsy of Scalp|DIAGNOSTIC_TEST: Blood draw|PROCEDURE: Skin Microbiome sampling|PROCEDURE: Hair Microbiome Sampling|DRUG: Pre-FMT Antibiotic Cocktail|DRUG: Bowel Prep,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT00069589,Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT00069589,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis|Autoimmune Hair Loss|Alopecia Partialis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"University of California, San Francisco, San Francisco, California, 94143, United States|University of Colorado - UCHSC - Health Science Center at Fitzsimons, Aurora, Colorado, 80010-7163, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Columbia University, New York, New York, 10032, United States|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States"
NCT05589610,Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05589610,NO,Alopecia Areata|Alopecia|Alopecia Totalis|Alopecia Universalis,DRUG: EQ101,ALL,ADULT,PHASE2,"Sinclair Dermatology, East Melbourne, Australia|Fremantle Dermatology, Fremantle, Australia|Premier Specialists, Kogarah, Australia|Veracity Clinical Research, Woolloongabba, Australia|Optimal Clinical Trials Limited, Auckland, New Zealand"
NCT04011748,Clinical Application of Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT04011748,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,COMBINATION_PRODUCT: Stem Cell Educator therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Throne Biotechnologies, Paramus, New Jersey, 07652, United States"
NCT02812342,Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02812342,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib ointment,ALL,"ADULT, OLDER_ADULT",PHASE2,"Yale-New Haven Hospital, New Haven, Connecticut, 06510, United States"
NCT03759340,"ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)",https://clinicaltrials.gov/study/NCT03759340,YES,Alopecia Areata|Alopecia Universalis|Alopecia Totalis,DRUG: ATI 502 0.46% Topical Solution,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Rogers, Arkansas, 72758, United States|Aclaris Investigator Site, Denver, Colorado, 80210, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Snellville, Georgia, 30078, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator SIte, Detroit, Michigan, 48202, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Saint Joseph, Missouri, 64506, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, Las Vegas, Nevada, 89148, United States|Aclaris Investigator Site, New York, New York, 10075, United States|Aclaris Investigator Site, Rochester, New York, 14623, United States|Aclaris Investigator Site, Portland, Oregon, 97223, United States|Aclaris Investigator Site, Greenville, South Carolina, 29607, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigational Site, Nashville, Tennessee, 37215, United States|Aclaris Investigational Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Houston, Texas, 77056, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States"
NCT02312882,Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02312882,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib,ALL,"ADULT, OLDER_ADULT",NA,"Stanford University, Stanford, California, 94305, United States"
NCT03532958,Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03532958,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: BNZ-1|DRUG: Normal saline,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT03551821,Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata,https://clinicaltrials.gov/study/NCT03551821,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: ATI-50002,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States"
NCT03155958,Ocular Finding in Alopecia Areata,https://clinicaltrials.gov/study/NCT03155958,NO,Hair Loss,,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT06283316,Systemic Treatments for Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT06283316,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis|Hair Loss|Hair Diseases|Alopecia|Alopecia Drugs|Autoimmune Diseases,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Erasmus University Medical Center, Rotterdam, Netherlands"
NCT03240627,Efficacy and Safety of LH-8 in Paediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT03240627,NO,Alopecia Areata|Pediatric Disorder,DRUG: LH-8|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE2|PHASE3,"Multicenter Clinical Trials, Sofia, Bulgaria|Centre Sabourand - Hospital Saint-Louis, 1, Avenue Claude Vellefaux, Paris, 75010, France|Clinical Research Center for Hair and Skin Science, Charité-Universitätsmedizin Berlin, Berlin, Berlin,, 10117, Germany"
NCT03873155,The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata,https://clinicaltrials.gov/study/NCT03873155,NO,Alopecia Areata|Social Anxiety,BEHAVIORAL: Mindfulness Based Cognitive Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"The University of Sheffield, Sheffield, South Yorkshire, S12LT, United Kingdom|Royal Hallamshire Hospital (Sheffield Teaching Hospital), Sheffield, South Yorkshire, United Kingdom"
NCT02197455,Tofacitnib for the Treatment of Alopecia Areata and Variants,https://clinicaltrials.gov/study/NCT02197455,YES,Alopecia Areata (AA)|Alopecia Totalis (AT)|Alopecia Universalis (AU),DRUG: Tofacitinib Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,"Yale University, New Haven, Connecticut, United States"
NCT01167946,Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01167946,NO,Alopecia Totalis|Alopecia Universalis|Ophiasic Alopecia,DRUG: methylprednisolone sodium succinate|DRUG: methylprednisolone sodium succinate|DRUG: methylprednisolone sodium succinate,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"King Khalid University Hospital, Riyadh, 11472, Saudi Arabia"
NCT02548689,PAI-1 Expression in Non-scarring Hair Loss,https://clinicaltrials.gov/study/NCT02548689,NO,Androgenetic Alopecia|Telogen Effluvium|Alopecia Areata,,ALL,ADULT,,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States"
NCT01023841,Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children,https://clinicaltrials.gov/study/NCT01023841,YES,Eyelash Hypotrichosis|Alopecia Areata,DRUG: bimatoprost ophthalmic solution 0.03%|DRUG: Vehicle Sterile Solution,ALL,CHILD,PHASE4,"Newport Beach, California, United States|São Paulo, Brazil"
NCT06357169,Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias,https://clinicaltrials.gov/study/NCT06357169,NO,Lichen Planopilaris of Scalp|Alopecia Areata,DEVICE: Venus Glow,ALL,ADULT,NA,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT03594227,"ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis",https://clinicaltrials.gov/study/NCT03594227,YES,Alopecia,DRUG: ATI-501 400mg BID (Low dose)|DRUG: ATI-501 600mg BID (Mid dose)|DRUG: ATI-501 800mg BID (High dose)|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Hot Springs, Arkansas, 71913, United States|Aclaris Investigator Site, Rogers, Arkansas, 72758, United States|Aclaris Investigator Site, Denver, Colorado, 80210, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Miami, Florida, 33137, United States|Aclaris Investigator Site, Sanford, Florida, 32771, United States|Aclaris Investigator Site, Snellville, Georgia, 30078, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator Site, Detroit, Michigan, 48202, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Saint Joseph, Missouri, 64506, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, Las Vegas, Nevada, 89148, United States|Aclaris Investigator Site, New York, New York, 10075, United States|Aclaris Investigator Site, Rochester, New York, 14623, United States|Aclaris Investigator Site, Portland, Oregon, 97223, United States|Aclaris Investigator Site, Greenville, South Carolina, 29607, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigator Site, Nashville, Tennessee, 37215, United States|Aclaris Investigational Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Houston, Texas, 77056, United States|Aclaris Investigator Site, San Antonio, Texas, 78213, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States|Aclaris Investigator Site, Norfolk, Virginia, 23502, United States"
NCT06292533,Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study,https://clinicaltrials.gov/study/NCT06292533,NO,Androgenic Alopecia|Alopecia,DEVICE: Er:YAG laser,ALL,"ADULT, OLDER_ADULT",NA,
NCT04341363,Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04341363,YES,Androgenic Alopecia,DEVICE: Tattoo machine,MALE,"ADULT, OLDER_ADULT",NA,"Yale University, New Haven, Connecticut, 06519, United States"
NCT06319781,"A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo",https://clinicaltrials.gov/study/NCT06319781,NO,Alopecia Areata|Vitiligo|Atopic Dermatitis|Psoriasis,OTHER: Observational,ALL,"ADULT, OLDER_ADULT",,"Sanos Clinic, Gandrup, Gandrup, 9362, Denmark|Sanos Clinic, Herlev, Herlev, 2730, Denmark|Sanos Clinic, Vejle, Vejle, 7100, Denmark"
NCT06409650,To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT06409650,NO,Alopecia,DRUG: KX-826 dosed at 2.5mg|DRUG: KX-826 dosed at 2.5mg|DRUG: KX-826 dosed at 5 mg|DRUG: KX-826 dosed at 5 mg|DRUG: Matching placebo to KX-826|DRUG: Matching placebo to KX-826,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Beijing Friendship Hospital, Capital Medical University, Beijing, China|Beijing Tongren Hospital, Capital Medical University, Beijing, China|China-Japan Friendship Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Xiangya Hospital Central South University, Changsha, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, China|Dermatology Hospital of Southern Medical University, Guangzhou, China|Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China|Huashan Hospital, Fudan University, Shanghai, China|Shenzhen People's Hospital, Shenzhen, China|The First Hospital of Hebei Medical University, Shijiazhuang, China|Suining Central Hospital, Suining, China|The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China"
NCT03052413,Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females,https://clinicaltrials.gov/study/NCT03052413,NO,Hair Loss,DIETARY_SUPPLEMENT: Nutrafol|DIETARY_SUPPLEMENT: placebo,FEMALE,ADULT,NA,"New Jersey Plastic Surgery, Montclair, New Jersey, 07042, United States|Sadick Research Group, New York, New York, 10075, United States"
NCT04205214,A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia,https://clinicaltrials.gov/study/NCT04205214,NO,Alopecia,BEHAVIORAL: Integrative Cognitive Behavioural Therapy,ALL,"ADULT, OLDER_ADULT",NA,"Royal Free Hospital, London, United Kingdom"
NCT04884347,Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects,https://clinicaltrials.gov/study/NCT04884347,NO,Hair Loss,DIETARY_SUPPLEMENT: Alline proMEN|DIETARY_SUPPLEMENT: Placebo,MALE,ADULT,NA,"Complife Italia S.r.l, Pavia, 27028, Italy"
NCT03689452,The Effect of Platelet Rich Plasma on Non-scarring Alopecia,https://clinicaltrials.gov/study/NCT03689452,YES,Androgenetic Alopecia|Alopecia,DEVICE: Platelet Rich Plasma|DRUG: Normal saline,FEMALE,"ADULT, OLDER_ADULT",NA,"Icahn School of Medicine at Mount Sinai, New York, New York, 10028, United States"
NCT02302053,Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair,https://clinicaltrials.gov/study/NCT02302053,NO,Hair Thinning,DIETARY_SUPPLEMENT: New Viviscal Professional Supplement|DIETARY_SUPPLEMENT: Placebo tablets,FEMALE,"ADULT, OLDER_ADULT",NA,
NCT03206567,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair,https://clinicaltrials.gov/study/NCT03206567,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Supplement capsules|OTHER: Placebo capsules,FEMALE,"ADULT, OLDER_ADULT",NA,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States"
NCT05970809,Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss,https://clinicaltrials.gov/study/NCT05970809,NO,Male Pattern Baldness|Androgenetic Alopecia|Hair Loss/Baldness|Hair Loss|Pattern Baldness,DEVICE: SAGA-001 (A)|DEVICE: SAGA-001 (B),MALE,ADULT,NA,"Ankara Bilkent Şehir Hastanesi Dermatoloji Klini, Ankara, Turkey|İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü Deri ve Zührevi Hastalıklar Ana Bilim Dalı Kocamustafa Paşa, Istanbul, Turkey"
NCT03976622,"Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata",https://clinicaltrials.gov/study/NCT03976622,NO,Vitiligo|Psoriasis|Alopecia Areata|Atopic Dermatitis,BIOLOGICAL: Blood samples|BIOLOGICAL: Skin biopsies,ALL,"ADULT, OLDER_ADULT",,"Service de Dermatologie - Hôpital Saint-André, Bordeaux, 33075, France"
NCT05210452,Treatment of Alopecia Using Follicular Stem Cells,https://clinicaltrials.gov/study/NCT05210452,NO,Alopecia,BIOLOGICAL: Follicular stem cells|OTHER: Standard treatment according to the clinical protocols,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,
NCT06355856,Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss,https://clinicaltrials.gov/study/NCT06355856,NO,Alopecia,DRUG: DNN.22.17.036|DRUG: 10573048700,MALE,ADULT,PHASE4,
NCT05339958,Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair,https://clinicaltrials.gov/study/NCT05339958,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol® Men Hair Growth Nutraceutical|OTHER: Placebo Supplement,MALE,ADULT,NA,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States|Therapeutic Clinical Research, San Diego, California, 92123, United States"
NCT04558242,Low Level Light Device as a Primary Therapy for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT04558242,NO,Androgenetic Alopecia|Hair Loss|Thinning Hair|Balding,DEVICE: Genix|DEVICE: Sham,ALL,"ADULT, OLDER_ADULT",NA,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States"
NCT04048031,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair,https://clinicaltrials.gov/study/NCT04048031,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Supplement Capsules|OTHER: Placebo Capsules,FEMALE,"ADULT, OLDER_ADULT",NA,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States"
NCT05332743,Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair,https://clinicaltrials.gov/study/NCT05332743,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Vegan Women's Hair Supplement,FEMALE,ADULT,NA,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States"
NCT04459650,A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer,https://clinicaltrials.gov/study/NCT04459650,NO,Alopecia,PROCEDURE: Platelet Rich Plasma system,ALL,ADULT,EARLY_PHASE1,"Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States"
NCT05213936,Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color,https://clinicaltrials.gov/study/NCT05213936,NO,Alopecia,DEVICE: Scalp cooling with hairstyle|DEVICE: Scalp cooling with conditioner and water emulsion,ALL,"ADULT, OLDER_ADULT",NA,"Montefiore Medical Center, Bronx, New York, 10461, United States"
NCT04897555,LLLT for Alopecia of the Eyebrow in Women,https://clinicaltrials.gov/study/NCT04897555,NO,Alopecia,DEVICE: LLLT,FEMALE,"ADULT, OLDER_ADULT",NA,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States|Bodian Dermatology, Great Neck, New York, 11021, United States"
NCT06362941,Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men,https://clinicaltrials.gov/study/NCT06362941,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplemnt|DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Men's Hair Growth Supplement,ALL,"ADULT, OLDER_ADULT",NA,"Dermatology Consulting Services, High Point, North Carolina, 27262, United States"
NCT06376409,Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females,https://clinicaltrials.gov/study/NCT06376409,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement,FEMALE,"ADULT, OLDER_ADULT",NA,"Integrative Skin Science and Research, Sacramento, California, 95815, United States"
NCT02297360,Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair,https://clinicaltrials.gov/study/NCT02297360,NO,Hair Thinning,DIETARY_SUPPLEMENT: Viviscal Extra-Strength Supplement|OTHER: Placebo tablet,FEMALE,"ADULT, OLDER_ADULT",NA,
NCT04721548,Treatment of Androgenetic Alopecia in Men for 24 Weeks,https://clinicaltrials.gov/study/NCT04721548,NO,Alopecia,DRUG: Minoxidil Topical Foam|DRUG: Placebo,MALE,"ADULT, OLDER_ADULT",PHASE3,"Eurofarma Laboratorios S.A, São Paulo, 06696-000, Brazil"
NCT03488108,Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women,https://clinicaltrials.gov/study/NCT03488108,YES,Alopecia,OTHER: Platelet Rich Plasma|DRUG: Minoxidil Foam,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Mayo Clinic Florida, Jacksonville, Florida, 32224, United States"
NCT02288858,To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair,https://clinicaltrials.gov/study/NCT02288858,NO,Hair Thinning,DIETARY_SUPPLEMENT: Viviscal Oral Supplement Tablets,ALL,ADULT,NA,"Stephens Associates Inc., Richardson, Texas, 75081, United States"
NCT03284021,Fraxel Laser for Alopecia,https://clinicaltrials.gov/study/NCT03284021,NO,Alopecia,DEVICE: Fractional erbium-glass 1550 nm laser,ALL,"ADULT, OLDER_ADULT",NA,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States"
NCT02087319,Effect of PRP on the Therapy for Hair Growth,https://clinicaltrials.gov/study/NCT02087319,NO,Hair Loss/Baldness,"OTHER: hair loss, baldness (patient's own platelet-rich plasma)",ALL,"ADULT, OLDER_ADULT",NA,"China Medical University Hospital, Taichung, Taiwan"
NCT05391178,Improving Disease Severity,https://clinicaltrials.gov/study/NCT05391178,NO,Psoriasis|Alopecia Areata|Polymorphous Light Eruption,OTHER: Lumiton yarn sleeve|OTHER: Lumiton yarn hat|OTHER: Lumiton yarn shirt,ALL,"ADULT, OLDER_ADULT",NA,"Wake Forest University Health Sciences, Dermatology, Winston-Salem, North Carolina, 27157, United States"
NCT05984862,Role of Bandage After FUE Hair Transplantation,https://clinicaltrials.gov/study/NCT05984862,NO,Hair Loss/Baldness,DEVICE: Bandage,ALL,"ADULT, OLDER_ADULT",NA,
NCT02676310,"Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)",https://clinicaltrials.gov/study/NCT02676310,NO,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: Bimatoprost,MALE,ADULT,PHASE1,"DermResearch, LLC, Austin, Texas, 78759, United States|J&S Studies Inc., College Station, Texas, 77845, United States|E&R Research Foundation, Lynchburg, Virginia, 24501, United States"
NCT02014584,Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT02014584,YES,Alopecia,DRUG: Dutasteride|DRUG: Placebo,MALE,ADULT,PHASE3,"GSK Investigational Site, Santiago, Región Metro De Santiago, 7580206, Chile|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Shatin, Hong Kong|GSK Investigational Site, Chungcheongnam-do, Korea, Republic of|GSK Investigational Site, Daejeon, 301-721, Korea, Republic of|GSK Investigational Site, Gwangju, 501-757, Korea, Republic of|GSK Investigational Site, Gyeonggi-do, 463-707, Korea, Republic of|GSK Investigational Site, Incheon, 400-711, Korea, Republic of|GSK Investigational Site, Jeonju-si, Jeollabuk-do, 561-712, Korea, Republic of|GSK Investigational Site, Kangwon-Do, 220-701, Korea, Republic of|GSK Investigational Site, Pusan, 602-739, Korea, Republic of|GSK Investigational Site, Seoul, 110-744, Korea, Republic of|GSK Investigational Site, Seoul, 134-090, Korea, Republic of|GSK Investigational Site, Seoul, 143-729, Korea, Republic of|GSK Investigational Site, Seoul, 156-755, Korea, Republic of|GSK Investigational Site, Singapore, 169608, Singapore|GSK Investigational Site, Taipei, 106, Taiwan|GSK Investigational Site, Taipei, Taiwan"
NCT02919735,"Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)",https://clinicaltrials.gov/study/NCT02919735,NO,Alopecia,DRUG: CG 428 cutaneous solution|DRUG: Placebo cutaneous solution,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"CHUV Lausanne, Lausanne, 1011, Switzerland"
NCT01145625,Clinical Trial in Females With Female Pattern Hair Loss,https://clinicaltrials.gov/study/NCT01145625,YES,Alopecia,DRUG: 5% Minoxidil|DRUG: 2% Minoxidil,FEMALE,"ADULT, OLDER_ADULT",PHASE3,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Academic Dermatology Associates, Albuquerque, New Mexico, 87106, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Oregon Medical Research Center, P.C., Portland,, Oregon, 97223, United States|NW Dermatology and Research Center, Portland, Oregon, 97210, United States|DermResearch, Inc, Austin, Texas, 78759, United States|Dermatology Research Center, Inc., Salt Lake City, Utah, 84124, United States|The Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada|Centre de Santé Sabouraud, Paris, Île-de-France, 75010, France|Klinik für Dermatologie, Venerologie und Allergologie, Clinical Research Center for Hair and Skin Science, Berlin, 10117, Germany|Royal Hallamshire Hospital, Sheffield, South Yorkshire, S10 2JF, United Kingdom"
NCT01831791,A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT01831791,YES,Alopecia,DRUG: Dutasteride 0.5 mg,MALE,ADULT,PHASE3,"GSK Investigational Site, Fukuoka, 812-0025, Japan|GSK Investigational Site, Osaka, 530-0057, Japan|GSK Investigational Site, Osaka, 532-0003, Japan|GSK Investigational Site, Tokyo, 103-0028, Japan|GSK Investigational Site, Tokyo, 160-0022, Japan"
NCT00801086,Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain,https://clinicaltrials.gov/study/NCT00801086,NO,Alopecia,DRUG: 7% (w/v) Tempol alcohol-based gel (MTS-01)|DRUG: alcohol-based gel,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Arizona, Tucson, Arizona, 85724, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States"
NCT02781311,A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males,https://clinicaltrials.gov/study/NCT02781311,YES,Alopecia,DRUG: Setipiprant|DRUG: Placebo|DRUG: Finasteride,MALE,ADULT,PHASE2,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|Petrus Center for Aesthetic Surgery & Hair Transplantation, Little Rock, Arkansas, 72205, United States|Therapeutics Clinical Research, San Diego, California, 92123, United States|Radiant Research, Inc., Santa Rosa, California, 95405, United States|DeNova Research, Chicago, Illinois, 60611, United States|Heartland Research Associates, LLC, Wichita, Kansas, 67207, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology Division of Clinical research, Minneapolis, Minnesota, 55455, United States|Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard, Winston-Salem, North Carolina, 27157, United States|Cleveland Clinic, Dept of Dermatology, Cleveland, Ohio, 44195, United States|NW Dermatology and Research Center, Portland, Oregon, 97210, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Penn State Hershey Medical Center Dermatology Research Office, Hershey, Pennsylvania, 17033, United States|Radiant Research, Inc., Greer, South Carolina, 29650, United States|DermResearch, Inc, Austin, Texas, 78759, United States|Suzzane Bruce and Associates P.A., The Center for Skin Research, Katy, Texas, 77494, United States|The Education & Research Foundation, Inc, Lynchburg, Virginia, 24501, United States"
NCT01111981,Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia,https://clinicaltrials.gov/study/NCT01111981,NO,Alopecia,DRUG: Clobetasol Propionate 0.05% Emollient Foam,FEMALE,"ADULT, OLDER_ADULT",PHASE4,"Callender Center for Clinical Research, Mitchellville, Maryland, 20721, United States"
NCT06146166,"The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome",https://clinicaltrials.gov/study/NCT06146166,NO,Hair Thinning,DIETARY_SUPPLEMENT: Oral herbal supplement|DIETARY_SUPPLEMENT: Oral placebo supplement,FEMALE,"ADULT, OLDER_ADULT",NA,"Integrative Skin and Research, Sacramento, California, 95815, United States"
NCT05296863,Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT05296863,NO,"Alopecia, Androgenetic|Hair Loss/Baldness",COMBINATION_PRODUCT: Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil|COMBINATION_PRODUCT: Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil|COMBINATION_PRODUCT: Placebo and 5% Minoxidil,MALE,ADULT,PHASE3,"Universitas Indonesia, Jakarta Pusat, Jakarta, 10430, Indonesia"
NCT00197379,The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00197379,NO,Alopecia,DRUG: roxithromycin,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan"
NCT05129800,Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study,https://clinicaltrials.gov/study/NCT05129800,NO,Androgenetic Alopecia|Hair Loss|Alopecia,OTHER: Platelet-rich plasma|OTHER: Mesotherapy,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT05460611,1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia,https://clinicaltrials.gov/study/NCT05460611,NO,Scarring Alopecia|Androgenetic Alopecia,DEVICE: Sciton HALO 1470nm Non-ablative laser,ALL,"ADULT, OLDER_ADULT",NA,"Montefiore Einstein Advanced Care, Elmsford, New York, 10523, United States"
NCT00418249,Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women,https://clinicaltrials.gov/study/NCT00418249,NO,Alopecia,DRUG: AS101,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Tel Aviv, Israel"
NCT03427905,Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia,https://clinicaltrials.gov/study/NCT03427905,NO,Hair Loss/Baldness|Alopecia,PROCEDURE: Lipoaspiration|PROCEDURE: Transplantation,ALL,"ADULT, OLDER_ADULT",NA,"Lebanese University, faculty of Sciences, section II and III, Beirut, 99, Lebanon"
NCT01651689,Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia,https://clinicaltrials.gov/study/NCT01651689,NO,Alopecia,,ALL,"ADULT, OLDER_ADULT",,"Siriraj hospital, Bangkok, 10700, Thailand"
NCT03331003,"""iRestore"" Light Therapy Apparatus",https://clinicaltrials.gov/study/NCT03331003,NO,Alopecia,DEVICE: low level light therapy|DEVICE: non-LLLT wavelength group,ALL,ADULT,NA,
NCT01904721,A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA),https://clinicaltrials.gov/study/NCT01904721,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: Bimatoprost Solution 1|DRUG: Bimatoprost Solution 2|DRUG: Bimatoprost Vehicle,MALE,ADULT,PHASE2,"Fridley, Minnesota, United States"
NCT01004809,AVODART® Alopecia Post-marketing Surveillance (PMS),https://clinicaltrials.gov/study/NCT01004809,NO,Alopecia,DRUG: Dutasteride,MALE,ADULT,,"GSK Investigational Site, Daejeon, 301-721, Korea, Republic of"
NCT01325337,Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia,https://clinicaltrials.gov/study/NCT01325337,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: bimatoprost Formulation A|DRUG: bimatoprost Formulation B|DRUG: bimatoprost Formulation C|DRUG: bimatoprost vehicle solution|DRUG: minoxidil 5% solution,MALE,ADULT,PHASE2,"Portland, Oregon, United States|Berlin, Germany"
NCT00441116,A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00441116,YES,Alopecia,DRUG: Dutasteride 0.5mg oral tablets,MALE,ADULT,PHASE3,
NCT01189279,Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia,https://clinicaltrials.gov/study/NCT01189279,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: bimatoprost Formulation A|DRUG: bimatoprost Formulation B|DRUG: bimatoprost Formulation C,ALL,ADULT,PHASE1,"Tempe, Arizona, United States"
